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Abstract 
This thesis describes the design and synthesis of clathrochelate metalloligands for the construction of 
molecular nanostructures. The low synthetic effort, versatility and stability of the clathrochelate metalloligands 
makes them particularly suited to the construction of coordination structures.  
Chapter 2 shows it is possible to control the geometry and the composition of metallasupramolecular 
assemblies via the aspect ratio of their ligands. Functionalized clathrochelate complexes with variable aspect 
ratios were used as rod-like metalloligands. Cubic FeII8L12 cages were obtained from a metalloligand with an 
intermediate aspect ratio. By increasing the length or by decreasing the width of the ligand, the self-assembly 
process resulted in the clean formation of tetrahedral FeII4L6 cages instead of cubic cages.  
Chapter 3 describes a simple one-step protocol, which allows large bipyridyl functionalized double 
clathrochelate metalloligands with an overall bent shape to be synthesized from easily accessible and/or 
commercially available starting materials. The ligands were used to construct PdII2L4-type coordination cages 
of unprecedented size. Furthermore, evidence is provided that these cages may be stabilized by close 
intramolecular packing of lipophilic ligand side chains.  
In Chapter 4, even larger triple clathrochelate metalloligands were used to form two PdII6L8-type coordination 
cages. With molecular weights of more than 15 kDa and Pd···Pd distances of up to 4.2 nm, these complexes 
are among the largest palladium cages described to date.  
In the 5th chapter, the stability of five different [Pdn(N-donor)m]2n+ assemblies was examined by performing 
disassembly experiments with pyridine and with trifluoroacetic acid. Pyridine-induced disassembly was found 
to be most pronounced for Pd complexes containing N-donor ligands of low basicity. At the same time, these 
assemblies displayed high acid resistance. The contrasting stability in the presence of acid or pyridine can be 
used for the pH-controlled switching between different metallosupramolecular structures. 
The final research section (Chapter 6) shows that the addition of a metastable-state photoacid to solutions 
containing metal-ligand assemblies renders the systems light responsive. Upon irradiation, proton transfer 
from the photoacid to the ligand is observed, resulting in disassembly of the metallasupramolecular structure. 
In the dark, the process is fully reversed. Light-induced switching was demonstrated for six different 
metal-ligand assemblies containing PdII, PtII or RuII complexes and bridging polypyridyl ligands. The 
methodology allows the liberation of guest molecules using light as a stimulus. 
 
Key words: Clathrochelate complexes, metalloligands, self-assembly, thermodynamic stability, photoacid, 
supramolecular chemistry 
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Résumé 
Cette thèse décrit la conception et la synthèse de métallo-ligands clathrochélate pour la construction de 
nanostructures moléculaires. Le faible effort synthétique, la versatilité et la stabilité des métallo-ligands 
clathrochélate les rend particulièrement intéressant pour la construction de structures de coordination. 
Le chapitre 2 montre qu’il est possible de contrôler la géométrie et la composition d’assemblages métallo-
supramoléculaires via le ratio et l’aspect de leurs ligands. Les complexes de clathrochélate fonctionnalisés avec 
divers ratios et aspects ont été utilisés comme métallo-ligands semblable à des barres. Des cages cubiques de 
type FeII8L12 ont été obtenues à partir d’un métallo-ligand avec un aspect et un ratio intermédiaire. En 
augmentant la longueur ou en diminuant la largeur des ligands, le processus d’auto-assemblage résulta dans 
la formation de cages tétraédriques de type FeII4L6 au lieu de cages cubiques. 
Le chapitre 3 décrit un protocole simple en une étape qui permet à de large double métallo-ligands bipyridyl 
clathrochélate avec une forme globale courbée d’être synthétisés à partir de matériaux de départ facilement 
accessible ou/et commercialement disponibles. Les ligands ont été utilisés pour construire des cages de 
coordination de type PdII2L4 de taille sans précédent. En outre, la preuve est fournie que ces cages peuvent être 
stabilisées par un empaquetage intramoléculaire aidé par des ligands à chaine latérale lipophile.  
Dans le chapitre 4, des métallo-ligands de type triple clathrochélate encore plus large ont été utilisés pour 
former deux cages de coordination de type Pd6L8. Avec des poids moléculaires de plus de 15 kDa et des 
distances Pd···Pd allant jusqu’à 4.2 nm, ces complexes comptent parmi les plus large cages au palladium 
décrites à ce jour. 
Dans le 5ème chapitre, la stabilité des cinq différents assemblages [Pdn(N-donor)m]2n+ a été examinée par des 
expériences de désassemblage avec de la pyridine et de l'acide trifluoroacétique. L'assemblage le plus 
prononcé induit par la pyridine a été trouvé pour les complexes de Pd avec des ligands N-donneur de faible 
basicité. Dans le même temps, ces assemblages ont montré une haute résistance aux acides. La stabilité 
contrastante en présence d'acide ou de pyridine peut être utilisée pour la commutation de différentes 
structures metallosupramoléculaires contrôlée par le pH. 
La section de recherche finale (chapitre 6) montre que l’addition de photo-acides dans un état métastable à 
des solutions contenant des assemblages de métaux-ligands rend le système sensible à la lumière. Sur 
irradiation, le transfert du proton du photo-acide au ligand est observé, résultant dans le désassemblage de la 
structure métallo-supramoléculaire. Dans le noir, le processus est complètement inversé. La commutation 
induite par la lumière a été démontrée pour six assemblages métal-ligand différent contenant des complexes 
de PdII, PtII ou RuII et des ligands poly-pyridyl servant de pont. 
 
Mots clés: Complexes clathrochélate, métallo-ligands, auto-assemblage, stabilité thermodynamique, photo-
acide, chimie supramoléculaire 
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 Introduction 
 
Part of this chapter (1.2) is based on published work: 
“Clathrochelate Metalloligands in Supramolecular Chemistry and Materials Science”[1] 
S. M. Jansze, K. Severin, Acc. Chem. Res., 2018, 51, 2139–2147 
Reprinted in an adapted version with permission from the American Chemical Society and all authors. 
S. M. Jansze has contributed by writing text and by constructing figures for this publication. 
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1.1 Discrete molecular nanostructures by coordination-driven self-assembly 
The construction of complex structures from simple building blocks is something everyone can relate to, as we 
remember our childhood days when we were building complex systems with our toy building blocks. 
Supramolecular chemistry is a subject area based on self-assembly to build complex nanostructures from easily 
accessible building blocks.  
Supramolecular chemistry has recently gained novel general attention with the awarding of the 2016 Nobel 
prize for chemistry to professors Sauvage, Stoddart and Feringa. Their work on “the design and synthesis of 
molecular machines” employs supramolecular chemistry to construct complex systems where motion can be 
controlled on a molecular-level.[2] Nobel prize winner professor Lehn described supramolecular chemistry in 
1987 as the “chemistry beyond the molecule”.[3] The formation of most supramolecular complexes is based on 
self-assembly. Self-assembly processes require the design of an unmediated system that under certain 
conditions forms a predefined supramolecular structure.[4] This self-assembly method facilitates the 
construction of complex and tunable systems.[5] The meticulous design of the individual molecular building 
blocks and comprehensive insight into the self-assembly processes are crucial to develop elaborate 
supramolecular complexes with a manifold of functions.  
The self-assembly process can be driven by a multitude of chemical interactions, including van der Waals forces, 
hydrogen-bonding, π-π stacking and metal-ligand coordination.[6] Although different combinations of these 
interactions can play a role in self-assembly, this thesis will focus on coordinative metal-ligand bonds. 
Coordination-driven self-assembly requires two types of molecular building blocks: an acceptor, often a metal 
ion with available coordination sites, and a donor, which can be any functional group possessing Lewis basicity. 
In this thesis, the focus will lie on two specific types of metal-ligand assemblies, mainly the systems based on 
[PdII(N-donor)4]2+ complexes are introduced (Chapter 1.1.1) and then molecular nanostructures based on 
subcomponent self-assembly are also briefly discussed (Chapter 1.1.2).  
An interesting feature of the metal-ligand bond is that they are non-covalent and reversible, which is of great 
importance for the self-assembly process. The reversibility of the bond allows for the organization of the 
building blocks into the thermodynamically most favorable state. Based on the conformation and angle of the 
donor and acceptors, the final architecture of the coordination complex becomes predictable. The meticulous 
design of individual building blocks plays an important role here. The ligands containing the donor-groups can 
have a wide-variety of shapes and sizes,[7] and can be selected to suit the desired properties of the 
supramolecular complex.[8] The research in this thesis describes a multitude of N-donor ligands, but the focus 
will lie on clathrochelate metalloligands, which will be further introduced in Chapter 1.2.  
Generally, supramolecular complexes can be divided into two main classes, namely discrete structures,[9] like 
cages,[10] macrocycles[11] and knots,[12] or polymeric structures, like MOFs[13] and gels.[14] Considering the 
research described in this thesis, the focus will mainly lie on the description of discrete supramolecular 
structures, also referred to as molecular nanostructures.  
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1.1.1 Metal-ligand assemblies based on [PdII(N-donor)4]2+ complexes 
The Pd(II) ion is a square-planar metal-center, meaning it has a total of four available coordination sites, of 
which the directionality is on the corners of a square on the same plane. This is a typical geometry for metal 
complexes with the d8 configuration. Cis or trans blocking of the square planar Pd(II) results in 90º and 180º 
acceptor-angles, respectively. Molecular structures based on these cis- or trans-blocked Pd(II) metal-acceptors 
have also been widely studied,[15] but will not be the focus of this thesis.  
Particularly suitable donors for coordination to the Pd(II) ion are neutral N-donors, like pyridyl and imidazole 
groups. Due to unfavorable hard-soft interactions between the ligand and the metal, oxygen-based donors are 
less suitable for the formation of supramolecular structures from Pd(II), although they have been employed 
before.[16] The vast majority of discrete supramolecular structures from Pd(II) ions are based on ditopic and 
tritopic ligands with specific angles between the donors. This sub-chapter will therefore describe the recent 
advances in the construction of discrete supramolecular structures based on ditopic and tritopic N-donor 
ligands and square-planar Pd(II) metal centers. 
When combining ditopic N-donor ligands with square planar Pd(II), generally PdIInL2n-type molecular 
nanostructures are formed (Figure 1.1). The assemblies with the lowest nuclearity are the PdII2L4 cages, which 
are based on ditopic ligands with an overall bent shape.[17] Due to the relatively large cavity in these molecular 
complexes, shaped like an oval capsule, they have been studied for a multitude of applications. Examples are 
host-guest chemistry,[17a, 18] medicinal inorganic chemistry,[19] improved catalysis of a Diels-Alder reaction,[20] 
and a light-switchable version of this complex has been developed.[21] The group of Crowley has shown that 
the 1,2,3-triazole unit, known for the CuAAC “click reaction, could be used as the N-donor ligand, giving rise 
to a wide variety of functional ligands that form coordination complexes with Pd(II).[22] The functionality of the 
complexes can be adjusted by changing the shape, size or functional groups within the linkers.[8b, 23] Further 
details about these about these PdII2L4-type coordination cages are discussed in Chapter 3 of this thesis.  
 
Figure 1.1. Examples of PdnL2n structures that can form from ditopic N-donor ligands. 
The molecular nanostructures that contain ditopic ligands and either three or four PdII ions most commonly 
are double triangle macrocycles or double walled tetrahedrons, respectively.[24] The mechanism to form either 
the PdII3L6 macrocycle or the PdII4L8 tetrahedron seem closely related, and have been studied for these 
complexes quite extensively.[25] The formation of one or the other architecture are for example the solvent or 
environment in which the building blocks are present.[26] 
There are, to the best of my knowledge, only two examples of molecular nanostructures containing five Pd II 
and ditopic ligands known to date, and the geometry is like a ring,[27] or a star[28] from a combination of two 
different ditopic ligands.  
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For molecular nanostructures based on ditopic ligands and six or more PdII ions, Fujita and coworkers have 
shown that the angle between the N-donors of the ligands plays an important role in which type of assemblies 
will be formed.[29] His work describes the utilization of 4-pyridyl functionalized ditopic ligands to form 
approximately spherical complexes. (Figure 1.2.) The smallest of these structures, is a PdII6L12 octahedron, 
which forms when there is an approximately 90º angle between the N-donors of the ligands.[30] The group of 
Fujita then went on to show that if this angle between the donors is increased towards ~120º, the assembly 
that forms will be the cuboctahedron PdII12L24.[31] Further increasing the angle between the donors to 
approximately 135º resulted in the even larger rhombicuboctahedron with a stoichiometry of PdII24L48.[32] Last 
but not least, the group of Fujita recently demonstrated the synthesis and characterization of the 
icosidodecahedron PdII30L60, which is, with a maximum Pd···Pd distance of 7.4 nm, by far the largest structurally 
characterized Pd(II) containing supramolecular complex known to date.[33] An interesting design feature that 
was shown with these spherical complexes, was the construction of double-layered spheres from covalently 
linked dual ditopic ligands, to make a smaller PdII12L24 cage within a larger PdII12L24 cage.[34]  
 
 
Figure 1.2. Examples of the ligands utilized by the group of Fujita, displayed below the structures are the 
optimal angle of the ligand, the stoichiometry of the formed complexes and estimated diameter of the 
assemblies they form when combined with square-planer Pd(II). 
To make their large structures adopt functionality, Fujita and coworkers studied the introduction of for example 
guest-binding groups to the PdII12L24 cages.[31] By simply functionalizing the ligands used for the self-assembly 
of these complexes they could introduce 24 groups on both the interior or the exterior of the cage complexes. 
They showed examples where the exterior of the cages are functionalized with sugars,[35] which can aggregate 
upon addition of lectin or functionalized with oligonucleotides,[36] which could lead to selective complexation 
with the complementary oligonucleotides.  
The interior functionalization of their complexes led, for example, to light-induced control over the 
hydrophobicity of the cavity,[37] endohedral radical polymerization of MMA,[38] and template synthesis of 
monodisperse silica nanoparticles.[39] 
The molecular structures can also interlock to form higher nuclearity cage structures.[40] Extensive studies on 
interlocked structures have mainly been performed on a range of PdII2L4 cages which can be triggered to 
interlock[40a, 41] to create dimers or trimers that possess new cavities and functionalities.[42] For example, 
interlocking can be triggered by the addition of halides, and the new cavity that forms can encapsulate neutral 
small-molecule guests.[43]  
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A final set of structures based on square-planar Pd(II) that is particularly interesting are the PdII6L8-type 
coordination cages. They are formed from tritopic N-donor ligands that are divergently organized. 
Coordination of these ligands to Pd(II) gives relatively large coordination structures from a low number of 
building blocks (Figure 1.3). An early example by the group of professor Hardie showed tritopic 
cyclotriveratrylene-based ligands which are used to form a structure of around 3 nm in size.[44] More recent 
examples have been an assembly from imidazole-based ligands by Mukherjee and coworkers.[45] The same 
group has shown the synthesis of a redox active water soluble PdII6L8 coordination cage.[46] The host-guest 
chemistry of a large PdII6L8 structures was studied by Crowley and coworkers and they showed the size selective 
encapsulation of anionic guests.[47] A more extensive discussion on PdII6L8-type coordination complexes can be 
found in Chapter 4 of this thesis.  
 
Figure 1.3. Graphical representation of PdII6L8 cage structure based on tritopic ligands. Blue: Pd(II) ions and 
orange: ligands.  
 
1.1.2 Molecular nanostructures based on subcomponent self-assembly 
Imines are known to form from a primary amine and aldehydes or ketones. They are generally unstable under 
aqueous conditions. In 2004 the research group of professor Nitschke showed that imines can be stabilized in 
aqueous conditions upon the coordination of a metal ion.[48] Multiple of these imine units will self-assembly 
around one metal center. This method of subcomponent self-assembly has been developed into an extensive 
set of functional supramolecular structures.[10a, 10e] For the design of molecular nanostructures from 
subcomponent self-assembly, the most commonly used conformation is when a M2+ ion, an aromatic primary 
amine and a formylpyridine are combined, and three of these imine units coordinate to the metal center, as is 
depicted in Figure 1.4. 
 
Figure 1.4. The coordination motif of three stabilized imines around one M(II) metal centre.  
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In 2008, the Nitschke group reported a water-soluble tetrahedral structure from commercially available 
2-formylpyridine and 4,4-diaminobiphenyl-2,2’disolufonic acid using Fe(II) as the metal center.[49] Later, it was 
demonstrated this cage structure is able to encapsulate and stabilize white phosphorus[50] and selectively 
encapsulate greenhouse gas SF6.[51] 
It was shown that the self-assembly of p-toluidine and 6,6’-diformyl-3,3’-bipyridine can result in a range of 
discrete supramolecular structures of the general formula MII2nL3n or polymer (MIIL)n, depending on the metal 
(M2+) or anion (A-) that are used for the subcomponent self-assembly (Scheme 1.1.).[52] For example, 
supramolecular cages were formed with the formula MII2nL3n with n = 2, 3, 4, 5 and 6. It was reasoned that the 
anions acted as a template during the self-assembly process, thereby thermodynamically favoring one 
assembly over the other. In case of the CdII assemblies, some other templates, like F-, Cl-, Br-, N3-, OCN- and 
HF2- were additionally employed.[52b]  
 
Scheme 1.1. The self-assembly of a range of MII2nL3n coordination structures from one ligand (L) by using 
different metal ions (M2+) and different anions (A-). 
This method of subcomponent self-assembly is further discussed in Chapter 2 of this thesis.   
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1.2 Clathrochelate metalloligands as building blocks in supramolecular 
chemistry 
Metalloligands are ligands which are based on a coordination complex. They often offer an ease of synthesis 
and the possibility to adapt the functional groups present on the ligands. The predetermined and well-defined 
electronic and structural preferences of the coordination complexes within the ligand facilitate rational design 
of the metalloligands to construct supramolecular structures.[53] 
1.2.1 Clathrochelate complexes 
Coordinatively saturated complexes can be formed by encapsulation of metal ions within macropolycyclic 
ligands. Busch suggested the term ‘clathrochelate’ to describe complexes of this kind.[54] Alternatively, they are 
sometimes referred to as ‘cage complexes’.[55] If the encapsulated ions are alkali or alkaline earth metal ions, 
the term ‘cryptate’ is commonly employed.[56] Early examples of transition metal clathrochelates were reported 
by the groups of Rose,[57] Holm,[58] Goedken,[59] and Sargeson[60] (Figure 1.4). 
 
Figure 1.4. Early examples of transition metal clathrochelate complexes. 
Following these initial reports, clathrochelate complexes have been studied extensively over the last decades. 
A comprehensive summary of the chemistry of clathrochelates, can be found in two books published in 2002[61] 
and in 2017.[55] Biological applications of clathrochelates are discussed in a recent review article.[62] 
In the following chapter the focus lies in particular on arylboron-capped clathrochelates. A convenient way to 
prepare these complexes is via a metal-templated condensation reaction of a dioxime and an arylboronic acid 
(Scheme 1.2). It is worth noting that alkylboronic acids can be incorporated as well.[55, 61] However, for the 
applications described below, arylboronic acids are more relevant. Fe2+ and Co2+ ions can be used to template 
these reactions. The Co2+ ion is a less efficient template, and the yields tend to be lower compared to what is 
observed for reactions with FeII salts. The 4d transition metal ruthenium can be incorporated by employing RuII 
or RuIII salts. In the latter case, in situ reduction to RuII is performed before complex formation.[63] 
 
Scheme 1.2. Synthesis of mononuclear, arylboron-capped clathrochelate complexes. 
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Cobalt clathrochelates have been isolated in the +1, the +2, and the +3 oxidation state.[64] In contrast, the 
chemistry of clathrochelates containing iron and ruthenium is largely limited to the +2 oxidation state, even 
though one can observe a quasi-reversible oxidation to the +3 state by electrochemistry. Using a dioxime with 
electron-withdrawing chloro substituents, the isolation of an FeI clathrochelate was recently accomplished.[65] 
Clathrochelate complexes can be decorated with functional groups in apical position (Scheme 1.2, R’) by using 
the corresponding arylboronic acid. Notably, donor groups such as pyridine or carboxylic acids can be 
employed without compromising the metal-templated reaction. The lateral groups (Scheme 1.2, R) attached 
to the clathrochelate can be modified via the dioxime. In several projects, we have used nioxime (dioxime with 
a cyclohexyl group). This dioxime is commercially available, and it gives rise to complexes, which tend to be 
well-soluble in organic solvents.  
Clathrochelate complexes are often very stable, and arylboron-capped complexes are no exception. The 
boronate ester groups are not susceptible to hydrolysis, and ligand exchange reactions are only observed 
under very forcing conditions. Considering the handling of these complexes, it is worth mentioning that FeII 
clathrochelates are not air and moisture sensitive.  
The inert character of boron-capped clathrochelates offers the opportunity to perform post-synthetic 
modifications. For example, clathrochelates can be used in palladium-catalyzed cross-coupling reactions 
(Scheme 1.3, left).[66] For modifications in lateral position, substitution reactions are an interesting option. It is 
possible to prepare clathrochelate complexes containing between one and six chloro atoms in lateral position. 
These complexes are amenable to substitution reactions using N-, O-, and S-nucleophiles (Scheme 1.3, 
right).[55, 61] There are other possibilities for the post-synthetic functionalization of clathrochelates, and a 
comprehensive discussion is provided in reference 55. 
 
Scheme 1.3. Post-synthetic modification of clathrochelate complexes. 
When metal-templated reactions are performed with phenoldioximes instead of simple 1,2-dioximes, dinuclear 
clathrochelate complexes are obtained (Scheme 1.4). The first example of such a complex featuring a 
methylboron cap was reported by Chaudhuri and co-workers.[67] Subsequently it was shown that 
arylboron-capped complexes can be prepared in a similar fashion.[68] Suited metal templates are Mn2+, Fe2+, 
Co2+ or Zn2+ ions. The resulting MII/MII clathrochelates have an overall charge of minus one. This feature is of 
importance for the applications in material science, which is not further discussed in this thesis. Dinuclear iron 
clathrochelates stand out because they are thermodynamically more stable than the corresponding cobalt or 
zinc complexes.[69] Furthermore, they are accessible as anionic FeII/FeII complexes or as neutral FeII/FeIII 
complexes.  
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Scheme 1.4. Synthesis of dinuclear, arylboron-capped clathrochelate complexes. 
As in the case of mononuclear clathrochelates, it is possible to introduce functional groups such as pyridines,[68] 
carboxylic acids,[70] or amines[71] in apical position by using the corresponding boronic acid during the synthesis. 
The post-synthetic introduction of functional groups is also possible via Pd-catalyzed cross-coupling 
reactions.[72] 
The lateral size of clathrochelates can be varied substantially by changing the groups R attached to the dioxime. 
Figure 1.3 shows the cores of two mononuclear and one dinuclear clathrochelate as determined by 
crystallography (apical aryl groups are removed for clarity). By comparing the space-filing representations of 
the structures, it is apparent that the clathrochelate with lateral phenyl groups (Figure 1.3b) is significantly 
wider than the clathrochelate based on glyoxime (Figure 1.3a). Even wider complexes can be obtained with 
dinuclear clathrochelates (Figure 1.3c). As discussed in the next section, the lateral size can be a decisive 
parameter for controlling the architecture of supramolecular assemblies. Generally, clathrochelates are well 
soluble in polar organic solvents due to their three-dimensional shape, which disfavors π-stacking interactions. 
It is possible to tune the solubility by modifying the lateral and apical groups R and R’. 
 
Figure 1.3. The molecular structures of mono- and dinuclear clathrochelate complexes with hydrogen atoms 
(a), phenyl groups (b), and t- butyl groups in lateral position (c). The aryl groups attached to the boron atoms 
are not shown for clarity. White: H, grey: C; blue: N; yellow: B; red: O; dark green: Co, orange: Fe. 
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1.2.2 Clathrochelate metalloligands for construction of discrete molecular nanostructures 
As described in the last section, boron-capped clathrochelates can be obtained in one-pot reactions from easily 
accessible starting materials. Furthermore, they are very robust compounds, and it is possible to decorate 
clathrochelates with a variety functional groups. These features make boron-capped clathrochelates interesting 
structural elements for the construction of metalloligands.[7, 53c] 
In the area of coordination-driven supramolecular chemistry, ligands with pyridyl donor groups are of special 
importance.[9b, 17a, 29] Iron clathrochelate complexes with terminal 4-pyridyl groups can be prepared in high yield 
by reaction of three commercially available compounds, namely nioxime, 4-pyridylboronic acid, and FeCl2.[66a] 
The two terminal N-donor atoms are 1.5 nm apart from each other (Figure 1.4, left side). This value is similar 
to what is found for pyridyl-functionalized porphyrins, which have been used extensively as metalloligands.[73] 
The dipyridyl clathrochelate was employed for the construction of heterometallic macrocycles containing 
iridium[74] or rhenium.[66a] A structurally related CoII clathrochelate was used to bridge two zinc 
tetraphenylporphyrin complexes.[75] In the presence of a sacrificial electron donor, light-induced reduction of 
the cobalt complex was observed.  
 
Figure 1.4. Clathrochelate-based metalloligands with terminal 4-pyridyl groups. The structures of the two 
shorter ligands are based on X-ray crystallography, whereas the structures of the other ligands were obtained 
by molecular modeling. The three longest ligands have octyl side chains, which are substituted by methyl 
groups for the clarity of this figure. 
It is straightforward to extend the length of clathrochelate-based dipyridyl ligands. One possibility is to use a 
mixture of a diboronic acid and 4-pyridylboronic acid during the synthesis. This kind of statistical reaction will 
lead to a mixture of products, from which a metalloligand with two clathrochelate cores can be isolated by 
selective precipitation or chromatography. Pyridyl-terminated metalloligands with lengths of 2.7 and 3.2 nm 
(Figure 1.4) were prepared in this fashion. A second possibility to extend the lengths of these ligands is to 
connect pre-formed clathrochelate complexes with iodo or alkynyl functions via Sonogashira coupling 
reactions. Using this strategy, ligands with lengths of up to 5.4 nm were prepared (Figure 1.4).[66a] 
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Pyridyl-terminated clathrochelate ligands were used by Ardavan and co-workers as linkers for heterometallic 
Cr7Ni rings (Scheme 1.5).[76] These paramagnetic rings with a well-defined S = ½ ground state are of interest 
as molecular spin qubits. By variation of the metalloligand, they were able to change the minimum distance 
between the paramagnetic rings in the range of 1.9–3.1 nm, thereby providing control over the inter-qubit 
quantum interactions. 
 
Scheme 1.5. A clathrochelate-based dipyridyl ligand as a nanoscale spacer for heterometallic Cr-Ni rings (Cr: 
dark green balls, Ni: pink balls). 
As described in Chapter 1.1.1, the combination of ditopic ligands with terminal pyridyl groups and Pd2+ ions is 
expected to give metal-ligand assemblies of the general formula PdIInL2n. For ligands with a linear geometry 
and 3-pyridyl groups at the end, assemblies of type PdII3L6 and PdII4L8 had been reported.[77] Larger assemblies 
of type PdII6L12 were obtained when clathrochelates with terminal 3-pyridyl groups were employed 
(Scheme 1.6a; the graphic of the cage is based on crystallographic data, and only one ligand is shown for 
clarity).[78] Most likely, assemblies with less than six palladium ions are disfavored due to steric interaction 
between the clathrochelate side chains. This hypothesis was corroborated by the following observation: when 
the reaction was carried out with a metalloligand containing a ‘thin’ clathrochelate core (R = H), the quantitative 
formation of a Pd4L8 tetrahedron instead of a PdII6L12 octahedron was observed (Scheme 1.6b).[79] Furthermore, 
it was found that the thermodynamic stability of PdII6L12 cages is strongly influenced by the lateral size of the 
clathrochelate side chains.  
 
Scheme 1.6. Synthesis of octahedral or tetrahedral palladium coordination cages (Pd: cyan balls). 
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The importance of the lateral size of the metalloligands was also noted in investigations using tetrapyridyl 
ligands. These ligands were synthesized by cross-coupling reactions using tetrabrominated clathrochelate 
complexes and 4-pyridylboronic acid. Subsequently, reactions with cis-blocked PtII complexes were studied. A 
first unexpected result was the formation of a PtII8L4 coordination cage with a gyrobifastigium-like geometry 
(Scheme 1.7a).[66b] The rectangular faces of the polyhedron are paneled by the tetratopic metalloligands. Later, 
we found that by varying the clathrochelate core of the ligand, we could also obtain PtII8L4 assemblies with a 
tetragonal barrel structure (Scheme 1.7b), pentagonal PtII10L5 barrels (Scheme 1.7c), and a PtII16L8 cage with 
an unprecedented square orthobicupola-like structure (Scheme 1.7d).[80] The latter assembly has a molecular 
weight of more than 23 kDa and a diameter of 4.5 nm, making it one of the largest, structurally characterized 
PtII cages in the CCDC data base. 
 
Scheme 1.7. Synthesis of platinum coordination cages using tetratopic metalloligands (Pt: green balls) 
 
In the previous section, we have shown that clathrochelate-based metalloligands are useful building blocks for 
the construction of molecularly defined nanostructures. They have also been used for polymeric materials and 
other functional materials,[68-70, 72, 81] but since this is beyond the scope of this thesis it will not be further 
addressed.  
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factor for the self-assembly of coordination 
cages 
 
This chapter is based on published work: 
“The Ligand Aspect Ratio as a Decisive Factor for the Self-Assembly of Coordination Cages”[79] 
S. M. Jansze, G. Cecot, M. D. Wise, K. O. Zhurov, T. K. Ronson, A. M. Castilla, A. Finelli, P. Pattison, E. Solari, R. 
Scopelliti, G. E. Zelinskii, A. V. Vologzhanina, Y. Z. Voloshin, J. R. Nitschke, K. Severin, J. Am. Chem. Soc. 2016, 
138, 2046-2054. 
Reprinted in an adapted version with permission from the American Chemical Society and all authors. 
S. M. Jansze has contributed by designing and performing experiments, writing text and constructing figures 
for this publication. The work of Giacomo Cecot (shared first-author to this publication) was focused on 
palladium-based coordination cages. His work is briefly mentioned in Chapter 1.2.2, but not further discussed 
in this chapter. 
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2.1 Introduction 
The structural outcomes of metallasupramolecular self-assembly processes are largely controlled by the nature 
of the building blocks, i.e. metal ions, ligands, and possibly templates.[9a, 9b, 82] From a design perspective, the 
ligand is arguably the most important building block, because chemists can use the repertoire of synthetic 
chemistry to make a vast collection of ligands with diverse structures and properties. 
As mentioned in Chapter 1, by choosing an appropriate ligand, it is possible to influence the size, the geometry, 
and the functionality of the resulting metallasupramolecular assembly. Several factors are known to be of 
importance in this context. Structural rigidity of the ligand is a prerequisite for the assembly of polynuclear 
assemblies, because flexible ligands tend to favor complexes of low nuclearity. For rigid ligands, the distance 
and the relative orientation of the donor atoms are key parameters, allowing control of the size and geometry 
of the final assembly. This point is nicely illustrated by work from the Fujita group, on the assembly of spherical 
coordination cages from different bent dipyridyl ligands and Pd(II) ions (Chapter 1).[29] The nature of the donor 
atom (e.g. oxygen vs. nitrogen) and the charge of the ligand are likewise important parameters. For example, 
it is possible to make heteroleptic assemblies by mixing cis-blocked L2MX2 complexes (M = PdII or PtII; X = 
weakly coordinating anion) with neutral N-donor ligands and anionic carboxylate ligands.[9b, 15] Taken together, 
the homoleptic [L2M(N-donor)2]2+ and L2M(O2CR)2 complexes are thermodynamically less stable than the 
mixed [L2M(N-donor)(O2CR)]+ complex, resulting in the clean formation of heteroleptic assemblies. 
Strategic functionalization of ligands with bulky groups can also be used to control the self-assembly behavior. 
For example, it is possible to favor heteroleptic complexes over homoleptic complexes by using two ligands, 
one of which has bulky groups in the vicinity of the donor atom(s).[83] In this case, the coordination of two bulky 
ligands to the same metal center is thermodynamically disfavored, pushing the system towards the formation 
of heteroleptic complexes. Steric interactions that are remote from the metal binding site have also been 
employed as an element of control,[84] but this strategy is less explored. 
The investigation described in this chapter deals with an underappreciated parameter in ligand design: the 
aspect ratio of a rigid rod-type ligand. We show that the length-to-width ratio of a ligand can be used to 
control the geometries of coordination cages. In particular, we demonstrate that entropically disfavored cubic 
cages are formed instead of tetrahedra if the aspect ratio of the ligand is reduced (Scheme 2.1).  
 
Scheme 2.1. Rigid rod-type ligands with different aspect ratios give rise to different coordination cages. 
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2.2 Results and discussion 
Clathrochelate-based metalloligands appear to be ideally suited to investigate the influence of the aspect ratio 
on self-assembly behavior. The length of the ligands can be modulated via the boronate ester cap, and the 
lateral size of the ligand can be varied by choosing an appropriate dioxime ligand. Functionalized 
clathrochelate complexes are thus intrinsically 3-dimensional metalloligands with rigid rod geometry. 
 
Scheme 2.2. FeII-based coordination cages with rigid rod-type ligands. 
For this investigation, we have focused on two types of coordination cages, which are known to form with rigid 
rod ligands. FeII-based cages of type FeII2nL3n can be obtained from ligands with two terminal formylpyridine 
groups upon reaction with aminobenzene derivatives and an FeII salt (Scheme 2.2a).[10a, 10b, 85] In similar fashion, 
FeII2nL3n cages are formed when ligands bearing terminal aniline groups react with 2-formylpyridine in the 
presence of FeII salts (Scheme 2.2b).[10a, 10b, 85d, 86]  
 
Scheme 2.3. a) Synthesis of the clathrochelates CC2.1, CC2.2 and CC2.3. Reagents and conditions: (i) MeOH, 
reflux, 4 h; (ii) TsOH (0.1 eq.), CHCl3/t-BuOH (4:1), 140 °C, 4 h. b) Synthesis of the clathrochelates CC2.4 and 
CC2.5. Reagents and conditions: (iii) MeOH, reflux, 4 h; (iv) H2, Pd/C, MeOH/CHCl3 (1.5:1), 50 °C, 4 h. 
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In order to synthesize a clathrochelate ligand with apical formylpyridine groups, we used an acetal-protected 
boronic acid, the synthesis of which has been reported previously.[87] Reaction with dimethylglyoxime, nioxime 
or diethylglyoxime and FeCl2 in methanol gave protected clathrochelates. The yield for these reactions is 
modest (21, 33 and 29%, respectively), because side-products are formed by a protodeboronation reaction. 
Clean deprotection of the acetal was achieved by reaction with p-toluenesulfonic acid using microwave heating 
to give the desired clathrochelates CC2.1, CC2.2 and CC2.3 (Scheme 2.3).  
For the syntheses of 4-aminophenyl-terminated clathrochelates, we also employed a protecting group 
strategy. Starting from (4-(dibenzylamino)phenyl)boronic acid,[88] we first synthesized the FeII clathrochelate 
complexes, which were subsequently deprotected through hydrogenation to give complexes CC2.4 and CC2.5 
with overall yields of 53% and 73%, respectively (Scheme 2.3). 
The new clathrochelates CC2.1−CC2.5 were characterized in solution by NMR spectroscopy and high 
resolution mass spectrometry.[79] In addition, we have analyzed the molecular structure of CC2.1 and of the 
HCl adducts of CC2.4 and CC2.5 in the solid state by single crystal X-ray crystallography. The structures are 
shown in Figure 2.1. The view along the B∙∙∙B axis reveals the pseudo C3-symmetry of the complexes. 
Furthermore, it is evident that the lateral size of the nioxime-based complex CC2.5 is significantly larger than 
that of the dimethylglyoxime-based complexes CC2.1 and CC2.4. 
 
Figure 2.1. Molecular structures of the clathrochelates CC2.1 (left), CC2.4·HCl (top right), and CC2.5·HCl 
(bottom right) in the crystal. A stick representation (side view, left) and a space filling representation (view 
along the B∙∙∙B axis, right) is given for each complex. Chloride anions are omitted for clarity. Gray: C, white: H, 
dark blue: N, green: B, red: O and orange: Fe. 
The coordination cages 2.1−2.3 were formed by heating an acetonitrile solution containing CC2.1, CC2.2 or 
CC2.3 (3 eq.), p-toluidine (6 eq.) and Fe(OTf)2 or Fe(NTf2)2 (2 eq.) at 50 °C for 18 h (Scheme 2.4). Workup 
allowed isolation of the cages in high yield (> 90%). The 1H NMR spectra of the products were very complex, 
in particular those of cages 2.2 and 2.3, which showed broad and ill-resolved peaks.[79] Such behavior is not 
unexpected because this type of cage is often observed as a mixture of diastereoisomers with different relative 
stereo chemistries of the iron centers at the corners.[10a, 10b, 85d, 89] Furthermore, the cages may not provide 
sufficient space for free rotation of the clathrochelate core. Restricted ligand rotation on the NMR time scale 
would lead to further reduction of the apparent symmetry.  
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The DOSY NMR spectra of 2.1−2.3 revealed the presence of large assemblies with a uniform diffusion 
constant.[79] However, the diffusion constant of 2.1 (4.43 × 10−6 cm2/s) was larger than that of 2.2 (2.2a: 2.89 
× 10−6 cm2/s; 2.2b: 2.85 × 10−6 cm2/s) and 2.3 (2.3a: 2.36 × 10−6 cm2/s; 2.3b: 2.62 × 10−6 cm2/s), even though 
ligands of the same lengths were employed (2.1−2.3). This result provides evidence that complexes 2.2 and 
2.3 are not typical tetrahedral coordination cages, but larger assemblies. 
 
Scheme 2.4. Synthesis of coordination cages 2.1−2.3 from L2.1 – L2.3. Conditions: CC2.1, CC2.2, or CC2.3 
(3 eq.), Fe(OTf)2 or Fe(NTf2)2 (2 eq.), p-toluidine (6 eq.), CH3CN, 50 °C, 18 h. 
High resolution ESI mass spectrometry revealed that 2.1 has the composition [FeII4(L2.1)6]8+ (Figure 2.2). The 
tetrahedral geometry is in line with what has been observed for other assemblies based on linear, rigid rod-type 
ligands with terminal formylpyridine groups.[10a, 10b, 85] The cages 2.2 and 2.3, on the other hand, have the 
composition [FeII8(L2.2/2.3)12]8+ (Figure 2.3 for 2.3b). 
 
Figure 2.2. High resolution ESI-MS spectrum of the tetrahedral cage 2.1. 
Ligand aspect ratio as a decisive factor for the self-assembly of coordination cages 
-18- 
 
Figure 2.3. High resolution ESI-MS spectrum cubic cage 2.3b (top), along with zoom-ins on the peaks at 1677 
and 1957 m/z (bottom). The simulated spectra are in blue placed above the experimental data. 
We infer 2.2 and 2.3 to possess an approximately cubic structure, with eight iron(II) centers at its vertices. Cubic 
coordination cages with FeII(N,N’-chelate)3 complexes as vertices have already been described.[90] These 
complexes are often based on fourfold-symmetric, face-capping ligands, and have an FeII8L6 stoichiometry. A 
cubic FeII8L12 cage has also been reported, but the coordinate vectors of its ligands are oriented at 120° with 
respect to each other,[90a] in contrast with the parallel coordinate vectors of L2.2 and L2.3. MII8L12 cages with 
other metal ions in the vertices (M = CuII, ZnII, NiII, CoII) have also been studied.[52a, 91] These cages were obtained 
using template effects,[52a] or ligands with some conformational freedom, resulting in variable coordinate 
vectors. In our case, the coordinate vectors of L2.2 and L2.3 should favor the formation of a tetrahedral FeII4L6 
cage. The fact that we observe an entropically disfavored FeII8L12 cage instead of a tetrahedron can be attributed 
to the small aspect ratio of ligands L2.2 and L2.3. Their lateral size is significantly larger than that of L2.1, and 
a tetrahedral geometry would lead to unfavorable steric interactions between the lateral -(CH2)4- or Et groups. 
Next, we investigated the formation of coordination cages starting from the aniline-terminated clathrochelates 
CC2.4 and CC2.5. The lateral size of these complexes is the same as for CC2.1 and CC2.2 (Me and -(CH2)4- 
side-chains), but condensation with 2-formylpyridine results in ligands with an increased distance between the 
two N,N’-chelating sites (Scheme 2.2). The aspect ratio of the metalloligands is thus increased. 
When CC2.4 or CC2.5 was combined with 2-formylpyridine and FeII(OTf)2 or FeII(NTf2)2, DOSY spectroscopy 
indicated all products to diffuse at indistinguishable rates. The 1H NMR spectra of cages 2.4 and 2.5 showed 
several sets of signals, indicating the presence of diastereoisomers.[10a, 10b, , 85d, 89] Clear evidence for the 
stoichiometry of the cages was again obtained by high resolution mass spectrometry: both cages have the 
composition FeII4L6 (Scheme 2.5). 
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Scheme 2.5. Synthesis of the coordination cages 2.4 and 2.5. Conditions: CC2.4 or CC2.5 (3 eq.), Fe(OTf)2 or 
Fe(NTf2)2 (2 eq.), 2-formylpyridine (6 eq.), CH3CN, 50 °C, 18 h. 
The decanuclear cages 2.4b and 2.5 were both analyzed by single crystal X-ray diffraction (Figure 2.4). Both 
cages crystallize as a racemic mixture of  and  isomers, with cage 2.4b showing a pseudo 
C3 symmetry axis, while cage 2.5 displays full crystallographic C3 symmetry. The four FeII(N,N’-chelate)3 
complexes in the vertices have an average distance of about 20 Å. The cavity of cage 2.4b has a size of 
approximately 480 Å3 as determined by VOIDOO calculations. For cage 2.5, the cavity is considerably smaller 
(377 Å3) because the lateral -(CH2)4- groups block part of the space inside the cavity (Figure 2.5). 
 
Figure 2.4: Molecular structures of the cages 2.4b (left) and 2.5 (right) in the crystal. Hydrogen atoms, counter 
anions, and solvent molecules are omitted for clarity. Gray: C, dark blue: N, green: B, red: O and orange: Fe. 
The formation of FeII4L6 cages with both aniline-terminated clathrochelates is consistent with the inference that 
aspect ratio and not the absolute width of the ligand is the decisive factor in controlling the geometry. In fact, 
ligand L2.5 (the condensation product of CC2.5 and 2 formylpyridine) and ligand L2.2 have the same lateral 
size, but L2.5 has an increased aspect ratio because the metal binding sites are farther apart. As a result of this 
difference, we observe an FeII8L12 cage with L2.2 but an FeII4L6 cage with L2.5. 
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Figure 2.5. Graphical representation of the VOIDOO calculations on cages 2.4b (left) and 2.5 (right), showing 
the detected void in the crystal structures. With the solvent molecules removed from the structure before 
calculation and the calculated void space indicated in yellow. C: Dark gray, N: dark blue, B: green, O: red, Fe: 
orange, H: white. 
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2.3 Conclusion 
The size and the geometry of a ligand is of pivotal importance for metal-based self-assembly reactions. The 
ligand aspect ratio is a parameter which is rarely discussed in this context, however. We have shown that the 
aspect ratio can be used as an element of control during the formation of coordination cages. If we also 
consider the work of Giacomo Cecot on PdII-based cages, it has been shown for two different types of cages 
that there is a switch towards a higher nuclearity structure when the length-to-width ratio of the ligand was 
reduced. In the case of FeII-based cages, we have obtained an unusual cubic FeII8L12 structure instead of the 
common FeII4L6 tetrahedron when a ligand with a small aspect ratio was employed. In the case of PdII-based 
cages, it was shown that it is possible to form PdII4L8 or PdII6L12 cages, depending on the aspect ratio of the 
ligand. Intramolecular steric interactions between the ligands are likely responsible for these changes in 
geometry. The reduced intra-ligand interactions in the larger cages are enthalpically favorable, thereby 
compensating for the entropic penalty associated with the formation of assemblies of higher nuclearity. 
Overall, our results provide clear evidence that the aspect ratio of a rigid rod-type ligand can be an important 
parameter for metal-based self-assembly reactions. In order to use this parameter as an element of control, it 
is desirable to employ a ligand which allows modulation of its aspect ratio without too much synthetic effort. 
Clathrochelate-based metalloligands appear ideally suited for this purpose, because their lengths, widths and 
functionalities can be varied easily.  
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 PdII2L4-type coordination cages 
up to three nanometers in size 
 
This chapter is based on published work: 
“PdII2L4-type coordination cages up to three nanometers in size”[80b] 
S. M. Jansze, M. D. Wise, A. V. Vologzhanina, R. Scopelliti, K. Severin, Chemical Science 2017, 8, 1901-1908. 
Reprinted in an adapted version with permission from the Royal Society of Chemistry and all authors. 
S. M. Jansze has contributed by designing and performing experiments, writing text and constructing figures 
for this publication. 
  
PdII2L4-type coordination cages up to three nanometers in size 
-24- 
3.1 Introduction 
As described in Chapter 1 of this thesis, coordination-driven self-assembly provides a formidable means to 
construct molecularly defined nanostructures through a bottom-up approach.[9b, 10a, 15, 17a, 18b, 29, 83c, 92] Ever larger 
and more complex metallasupramolecular structures have been reported in recent years, including 
topologically interesting architectures such as rotaxanes, catenanes, knots and links.[12a, 53d, 93] Current efforts in 
this area are increasingly focused on creating metal-based nanostructures with novel functions – such as 
coordination cages that act as selective catalysts for organic reactions.[5b, 10c, 85d, 94] However, addressing the 
ongoing structural challenges presented by coordination-driven self-assembly is similarly important, given the 
fundamental influence that the structure of a metallasupramolecular architecture exerts over its function. One 
such challenge is the creation of structurally defined assemblies of low symmetry starting from multiple 
chemically distinct building blocks (e.g. three different metal ions and three different ligands). Various 
strategies, such as orthogonal self-assembly,[95] have been employed to tackle this problem, but there remains 
scope for further development. Another, deceptively simple, challenge is size. In order to create large (> 2 nm), 
molecularly defined nanostructures by self-assembly, one has two options: a) the assembly of a large number 
of small building blocks; or b) the assembly of a small number of large building blocks. Obviously, one could 
also use a large number of large building blocks, but this approach would suffer from the drawbacks of option 
a) and b). 
Option a) is hampered by the fact that multicomponent metallasupramolecular assemblies are typically 
disfavored from an entropic point of view. Furthermore, intra- and intermolecular interactions must be precisely 
controlled in order to prepare an assembly of defined stoichiometry and geometry. The latter point is illustrated 
in works by the research group of Fujita, as described in Chapter 1 of this thesis. In order to avoid alternative 
structures and insoluble precipitates, they had to fine-tune the geometry, solubility and flexibility of the ligands 
they employed. The work of Fujita also highlights other difficulties in preparing large assemblies by 
coordination-driven self-assembly: the formation of kinetically trapped intermediates and the presence of 
large, solvent-filled voids.[33] These voids are not only problematic for structural analysis by X-ray 
crystallography, but they can also affect the structural integrity of the assembly upon solvent removal during 
isolation.[96] Related problems were also encountered for cages based on dynamic covalent chemistry.[97]  
Option b), the utilization of large building blocks, presents further challenges. First and foremost, the synthesis 
of such molecules can be highly demanding.[98] With the development of clathrochelates as metalloligands 
(Chapter 1) we have begun to address this issue. Continuing these efforts, this chapter describes the 
preparation of a new set of bent metalloligands with terminal 3-pyridyl groups. These ligands were used to 
form PdII2L4 complexes, which are significantly larger than the PdII2L4 cages described to date. Structural and 
spectroscopic data suggest that some of the assemblies are stabilized by close intramolecular packing of 
lipophilic ligand side chains. Such packing effects may offer a general means for circumventing the ‘void 
problem’ outlined above, and to stabilize metallasupramolecular assemblies in highly polar solvents. 
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3.2 Results and discussion 
An interesting aspect of the clathrochelate chemistry, as described in Chapter 1, is the fact that it is synthetically 
straightforward to prepare double clathrochelate complexes by using a mixture of a (functionalized) 
monoboronic acid and a diboronic acid (Scheme 3.1). Since the two boronic acids are incorporated in a 
statistical manner, the double clathrochelate complex is formed along with side products (e.g. the single 
clathrochelate complex with two capping groups B-R’). However, purification can be accomplished by 
chromatography or crystallization. We have previously used this synthetic approach to make linear 
metalloligands with terminal 4-pyridyl groups.[66a] For the work presented in this chapter, we have focused on 
bent ligands. 
 
Scheme 3.1. Synthesis of double clathrochelate complexes by combination of a monoboronic acid and a 
diboronic acid. 
Bent, ‘banana-shaped’ ligands with terminal pyridyl groups are well suited for the construction of PdII2L4 
coordination cages. In order to prepare cages with large cavities, relatively long and rigid ligands are required. 
Unsurprisingly, the synthesis of such ligands often requires substantial effort.[17a, 18b] We hypothesized that the 
utilization of double clathrochelate complexes as ligands would allow PdII2L4 cages, with unprecedented size, 
to be accessed in a straightforward manner. 
Using the approach outlined in Scheme 3.1, we have prepared the double clathrochelate complexes L3.1‒L3.4 
(Figure 3.1 right) by reaction of FeCl2 with dimethylglyoxime or nioxime in the presence of 3-pyridylboronic 
acid and either 1,3-benzenediboronic acid or (methylenebis(1,4-phenylene))diboronic acid. In order to 
suppress the formation of longer oligomers, we have used substoichiometric amounts of the diboronic acid. 
The small amount of oligomeric material that is still formed was removed by purification over a short silica 
plug. 
The main side product—the single clathrochelate complex with terminal 3-pyridyl groups—was separated out 
by size exclusion chromatography. This one-pot reaction protocol provides rapid access to the double 
clathrochelate metalloligands L3.1 ‒ L3.4 in yields between 39% and 59% (calculated based on the diboronic 
acid starting material). The new metalloligands were characterized by NMR spectroscopy and high-resolution 
mass spectrometry.[80b] In addition, we have analyzed the solid state structures of L3.1 and L3.2 by single crystal 
X-ray crystallography (Figure 3.1, right) The ligands show the expected bent structure and the FeII complexes 
display the usual distorted trigonal prismatic coordination geometry. 
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Figure 3.1. The metalloligands L3.1–L3.4 (left) and the molecular structures of the double clathrochelates L3.1 
and L3.2 as determined by single crystal X-ray diffraction (right). Hydrogen atoms and solvent molecules are 
omitted for clarity. Grey: C; blue: N; green: B; red: O; and orange: Fe. 
The PdII2L4 cages 3.1‒3.4 were prepared by addition of [Pd(CH3CN)4](BF4)2 to a suspension of the respective 
metalloligand in either CD3CN or DMSO-d6 (Scheme 3.2). The mixtures were then heated at 70 °C for 17 h, 
resulting in the formation of clear, deep orange solutions. The formation of Pd II2L4 cages was evidenced by 
NMR spectroscopy and high-resolution mass spectrometry.[80b] The 1H NMR spectra of the solutions showed a 
single set of signals for the aromatic protons of the terminal 3-pyridyl groups. (Figure 3.2) The proton signals 
belonging to the dioximato ligands gave rise to more complex signal patterns, indicating restricted rotational 
freedom of the clathrochelate cores (for the free ligands, rotation around the B···Fe···B axis is fast on the NMR 
time scale). For solutions of complex 3.1 in CD3CN (but not in DMSO-d6), we also observed a reduced symmetry 
for the four central phenylene spacers (Figure 3.2, bottom). Broadening of the 1H NMR signals of 
the -C6H4- group was observed at 328 K, indicating coalescence. These data provided initial evidence that the 
cages adopt a compact structure with close intraligand interactions. 
 
Scheme 3.2. Synthesis of the coordination cages 3.1–3.4. Conditions: [Pd(CH3CN)4](BF4)2 (0.5 eq.), CH3CN or 
DMSO, 70 °C, 17 h. 
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Figure 3.2. 1H NMR spectra of coordination cage 3.1 in DMSO-d6.(top) and CD3CN (bottom). 
DOSY NMR spectroscopy confirmed the formation of aggregates with a defined diffusion coefficient for all 
reactions. The high resolution ESI mass spectra of solutions of 3.2–3.4 showed dominant peaks for [Pd2L4]4+ 
complexes. For cage 3.1, on the other hand, a strong peak corresponding to [Pd2(L3.1)4(BF4)]3+ was observed, 
indicating that one of the four BF4‒ anions is more tightly bound. The strong binding of one BF4‒ was 
corroborated by 19F NMR spectroscopy. Two signals were observed, suggesting that the exchange of bound 
and unbound BF4‒ anions is slow on the NMR time scale. (Figure 3.3) 
 
Figure 3.3. Left: 19F NMR spectrum of cage 3.1 in DMSO-d6. Right: Zoom-in of the 3+ charged peak at 
1737 m/z in the HRMS spectrum of coordination cage 3.1 in CH3CN (bottom), with simulated spectrum shown 
in blue above. 
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Single crystal X-ray analyses were performed for cages 3.1, 3.2 and 3.4 (Figure. 3.4), revealing the expected 
PdII2L4 composition. These assemblies adopt a rugby ball-like, prolate-spheroid shape, with 
Pd(pyridyl)4complexes at the antipodes of the principal axis. With Pd···Pd distances of 2.1 nm (3.1), 2.0 nm (3.2), 
and 2.7 nm (3.3), the cages are very large compared to the PdII2L4 cages described so far (to the best of our 
knowledge, the largest crystallographically characterized PdII2L4 cage has a Pd···Pd distance of 1.7 nm).[96a] Most 
of the anions and the co-crystallized solvent molecules in the structures of 3.1, 3.2 and 3.4 are highly 
disordered, and the SQUEEZE algorithm was applied to solvent molecules during refinement. For complex 3.1, 
however, we were able to locate one BF4‒ anion inside the cage. (Figure 3.5) The anion is tightly encapsulated 
within 3.1, which is in line with the slow exchange kinetics observed by NMR spectroscopy and the MS data 
showing that one counter anion is retained. (Figure 3.4) 
 
Figure 3.4. Molecular structures of cages 1 (left), 2 (middle), and 3 (right), as determined by single crystal X-ray 
diffraction. Hydrogen atoms, solvent molecules and anions are omitted for clarity. Grey: C; dark blue: N; green: 
B; red: O; cyan: Pd and orange: Fe. 
 
Figure 3.5. Molecular structures of cage 3.1 with space filling representation of the encapsulated BF4- anion. 
Hydrogen atoms are omitted for clarity. Green: B; pink: F; grey: all other atoms. 
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The structures of cages 3.1 and 3.3 show tight, interdigitated packing of the cyclohexyl side chains of the 
clathrochelate complexes (Figure 3.4 and 3.6, left). The close packing is likely responsible for the hindered 
rotation observed by NMR spectroscopy. For cage 3.2, which has smaller methyl side chains, no such tight 
packing is observed (Figure 3.6, right). In the previous chapter we have shown that steric interactions between 
ligand side chains can thermodynamically destabilize a clathrochelate-based assembly[79] and, in view of these 
earlier results, we suspected that the sterically less congested cages 3.2 and 3.4 would prove to be more stable 
than the tightly packed cages 3.1 and 3.3. Surprisingly, the opposite is true. 
 
Figure 3.6. Parts of the structures of cage 3.1 (left) and cage 3.2 (right). The graphics depict the upper parts 
of the cages when viewed from the inside along the Pd∙∙∙Pd axis, with wire representations on the left and space 
filling representations on the right. Solvent molecules and anions are omitted for clarity. Grey: C; dark blue: N; 
green: B; red: O; cyan: Pd and orange: Fe. 
The relative thermodynamic stability of the smaller cages 3.1 and 3.2 in solution was examined by adding two 
equivalents of [Pd(CH3CN)4](BF4)2 to a solution of the cage in CD3CN (Scheme 3.3a). After heating to 70°C for 
2 h, the new equilibrium distribution was examined by 1H NMR spectroscopy. In the case of cage 3.1, only 
minor decomposition was observed. In the case of cage 3.2, on the other hand, substantial ligand 
rearrangement and cage decomposition was detected.[80b] These results indicate that cage 3.2 is less stable 
than cage 3.1 under these conditions. A stabilizing anionic template effect, resulting from the presence of a 
tightly encapsulated BF4‒ anion in 3.1, may offer an explanation for this trend.[52a, 99] 
 
Scheme 3.3. Decomposition experiments for evaluating the relative thermodynamic stability of the small cages 
3.1 and 3.2 (a) as well as for the large cages 3.3 and 3.4 (b). 
For the larger cages 3.3 and 3.4, we used DMSO-d6 as a solvent due to solubility problems in CD3CN. Adding 
further equivalents of [Pd(CH3CN)4](BF4)2 to solutions of the cages did not result in detectable decomposition, 
presumably since Pd2+ ions are well solvated in DMSO and hence less efficient competition agents. We 
therefore used an excess of pyridine-d5 to induce cage decomposition (Scheme 3.3b). The equilibrium 
composition was again determined by 1H NMR spectroscopy after a heating period of 2 h at 70°C. Substantial 
decomposition was observed for cage 3.4. In contrast, only low intensity new peaks were observed for cage 3.3, 
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indicating a superior stability of the latter. For the larger cages 3.3 and 3.4, stabilizing effects of the BF4‒ anions 
are unlikely to play an important role, as bound anions were observed neither by X-ray crystallography nor by 
NMR spectroscopy. Instead, we propose that the tightly packed cyclohexyl side chains are in fact a stabilizing 
factor for cage 3.3. The packing of the lipophilic cyclohexyl groups buries a substantial amount of apolar 
surface area and, in a polar solvent such as DMSO, this clustering is expected to be energetically favorable.[100] 
We have also attempted to examine the relative stabilities of the smaller cages 3.1 and 3.2 in DMSO. 
Interestingly, we were not able to achieve quantitative assembly of cage 3.2 from ligand L3.2 and 
[Pd(CH3CN)4](BF4)2, despite the unproblematic formation of cage 3.1 in DMSO. Apparently, 3.2 is not 
sufficiently stable to allow the assembly process to occur in a strongly coordinating solvent such as DMSO. As 
in the cases of 3.3 and 3.4, we propose that solvophobic effects contribute to the higher stability of cage 3.1 
(cyclohexyl side chains) when compared to cage 3.2 (methyl side chains).  
The experiments described above suggest that clathrochelate-based metalloligands with cyclohexyl side chains 
are particularly suited for the construction of PdII2L4 cages in polar solvents because solvophobic effects impart 
an additional stability to the assemblies. Therefore, we synthesized even larger cages using the extended 
metalloligands L3.5 and L3.6 (Figure 3.7). The synthesis of these ligands was accomplished in a similar fashion 
as described for L3.1 and L3.3, i.e. by using a mixture of 3-pyridylboronic acid and the corresponding diboronic 
acid along with nioxime and FeCl2. Purification by size exclusion chromatography gave the ligands L3.5 and 
L3.6 in yields of 48% and 49%, respectively. It should be noted that both ligands are rather flexible due to the 
presence of O(CH2)nO linkers (n = 3 or 5). In principle, highly flexible bipyridyl ligands can give rise to 
mononuclear complexes of the formula PdIIL2.[101] For L3.5 and L3.6, the sterically demanding clathrochelate 
complexes were expected to prevent such ‘back-biting’ of the ligand. 
 
Figure 3.7 The metalloligands L3.5 and L3.6. 
Finding a suitable solvent for reactions of L3.5 and L3.6 with [Pd(CH3CN)4](BF4)2 turned out to be challenging 
due to solubility problems. The best compromise was achieved with DMSO. The ligands L3.5 and L3.6 display 
very poor solubility in DMSO, but the addition of [Pd(CH3CN)4](BF4)2 resulted in the formation of a light orange 
solution along with some solid (Scheme 3.4). Analysis of the solution by high resolution mass spectrometry 
provided clear evidence for the presence of PdII2L4 complexes.[80b] Unfortunately, the low concentrations of the 
complexes in solution precludes analysis by NMR. 
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Scheme 4 Synthesis of the cages 3.5 and 3.6. 
Single crystals of 3.5 and 3.6 were obtained by slow diffusion of diisopropylether or diethyl ether into a solution 
of the cage in acetonitrile/DMSO (2:8). Crystallographic analyses show that PdII2L4-type complexes had formed 
in both cases (Figure 3.9). As observed for cages 3.1 and 3.3, the assemblies feature tightly packed cyclohexyl 
side chains of the clathrochelate complexes adjacent to the palladium ions. The proximity of neighboring 
clathrochelate complexes is reflected by the average distance of the four adjacent FeII centers. The values 
observed for 3.5 (0.84 nm) and 3.6 (0.83 nm) are close to what was found for 3.1 (0.83 nm) and 3.3 (0.83 nm). 
Apparently, the presence of more flexible O(CH2)nO linkers in 3.5 and 3.6 does not result in a more relaxed 
arrangement of the clathrochelate complexes. 
The O(CH2)5O linkers of cage 3.6 are bent outwards, whereas the O(CH2)3O groups of cage 3.5 are essentially 
straight. Consequently, the Pd···Pd distances of the two cages are similar (2.98 and 3.03 nm). The length of 
these cages is comparable to some of the longest cylindrical metallasupramolecular assemblies described to 
date.[102] 
 
Figure 3.9 Molecular structures of the cages 3.5 (left) and 3.6 (right) as determined by single crystal X-ray 
diffraction. Hydrogen atoms, solvent molecules and anions are omitted for clarity. Grey: C; dark blue: N; green: 
B; red: O; cyan: Pd and orange: Fe. 
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3.3 Conclusion 
We have synthesized and characterized novel, bent ditopic metalloligands with terminal 3-pyridyl groups. The 
preparation of these ligands is straightforward and relies on the FeII-templated formation of clathrochelate 
complexes. In order to access long metalloligands with two pyridyl-capped clathrochelate complexes, we have 
used a mixture of a diboronic acid and 3-pyridylboronic acid. This statistical synthesis gives rise to a mixture of 
products. However, purification by size exclusion chromatography is unproblematic. The ligands were used for 
the assembly of cage structures of the general formula (PdII2L4)(BF4)4.We characterized five of these assemblies 
by single crystal X-ray crystallography revealing remarkably large structures, spanning 2.0 nm to 3.0 nm. The 
thermodynamic stability of the cages was studied by competition experiments. These investigations revealed 
a surprising fact: cages based on ligands with sterically more demanding cyclohexyl side chains are more stable 
than cages based on ligands with smaller methyl side chains. We propose that the close packing of lipophilic 
cyclohexyl side chains contributes to the enhanced stability in polar solvents such as DMSO. Solvophobic 
effects of this kind are commonly observed for peptide or protein assemblies. For example, the aggregation of 
coiled-coil structures from amphiphilic α-helices is largely driven by the burial of hydrophobic surface area.[103] 
However, in the area of metallasupramolecular chemistry, these effects are rarely used in a deliberate manner, 
and demonstrate exciting potential as a more general tool to stabilize large, hydrophobic assemblies in polar 
solvents. 
 
 -33- 
 Inflating face-capped PdII6L8 
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4.1 Introduction 
Geometrical considerations are of central importance in synthetic metallosupramolecular chemistry. [9b, 10d, 22b, 
92b, 105] Metal complexes are characterized by the number and the orientation of the available coordination sites, 
and ligands are categorized by the orientation of the coordinate vectors. Knowing these parameters, it is 
possible to make a prediction of what kind of structure will form during the self-assembly process. Besides 
geometry, there are other factors such as template effects[40a, 106] or steric interactions,[83c, 84, 79] which can 
influence the self-assembly process. However, geometrical analyses have been remarkably successful in 
predicting and rationalizing the outcome of metal-based self-assembly. 
The absolute size of a ligand is irrelevant for a geometrical analysis. In principle, it should be possible to expand 
the size of a metallosupramolecular structure by increasing the size of the ligands, while keeping the number 
and orientation of the coordinate vectors constant. However, there is an obstacle. Larger ligands are typically 
more flexible, which makes the orientation of the coordinate vectors less defined. This flexibility could allow 
the formation of other assemblies along with – or instead of – the targeted structure. It should be noted that 
for some metal-ligand assemblies, ligand flexibility is more of an issue than for others, for example, in the case 
of the PdIInL2n-type coordination cages from Fujita and co-workers, as described in Chapter 1.  
The combination of PdII ions with divergent, tritopic N-donor ligands is expected to give assemblies of the 
general formula PdII3nL4n. There are also examples where the donor atoms are arranged in a non-divergent 
manner[101a, 102d, 107], but this is no further discussed. The assembly with the lowest number of building blocks, 
PdII3L4, can only form if some of the ligands act as chelates (two of the three N-donors bind to the same PdII 
ion).[108] If the N-donor position does not allow the formation of a chelate, the resulting assembly will contain 
at least six PdII ions and eight ligands.[45-47, 90d, 109] Since it is straightforward to design tritopic ligands which 
cannot form chelates, PdII3nL4n complexes appear to be a good starting point if the aim is to create particularly 
large assemblies based on ligands with nanoscale dimensions. 
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4.2 Results and discussion 
For this study, we have used the tritopic ligands L4.1 and L4.2 (Scheme 4.1). These metalloligands contain 
three diamagnetic FeII clathrochelate complexes. We have previously shown that FeII clathrochelates are robust 
and versatile building blocks for supramolecular chemistry (Chapter 1). A key advantage of these complexes is 
the ease of synthesis, because clathrochelates are formed in metal-templated multicomponent reactions. This 
advantage is particularly evident for L4.1 and L4.2, which were prepared by one-pot reactions using readily 
accessible or commercially available starting materials. Specifically, the synthesis is performed by heating a 
mixture of FeCl2 (4 eq.), nioxime (12 eq.), 3-pyridylboronic acid (5 eq.) and a triboronic acid (1 eq.) in a solvent 
mixture of chloroform, methanol, and acetone (30:7:1) (Scheme 4.1). Substoichiometric amounts of the 
triboronic acid were used to limit the formation of oligomers. As a consequence, a mono clathrochelate 
complex with two pyridylboronate ester caps was the major product for this reaction. Since this complex is 
much smaller than L4.1 and L4.2, it can be separated by size exclusion chromatography. The yields of the 
desired tritopic ligands are 57% (L4.1) and 49% (L4.2), respectively, when calculated based on the triboronic 
acid as limiting reagent. 
 
Scheme 4.1. One-pot synthesis of the metalloligands L4.1 and L4.2. The yields are calculated based on the 
triboronic acid as limiting reagent. 
L4.1 and L4.2 were characterized by NMR spectroscopy and high-resolution mass spectrometry.[104] In addition, 
both compounds were analyzed by single crystal X-ray diffraction. The results show that the N-donor atoms 
of L4.1 are approximately 2.2 nm apart (Figure 4.1). The presence of the additional phenyl spacers increases 
this value to 2.9 nm for ligand L4.2.  
The coordination cages 4.1 and 4.2 were prepared by combining ligand L4.1 or L4.2 (4 eq.) with 
[Pd(CH3CN)4](BF4)2 (3 eq.) in DMSO-d6 (Scheme 4.2). Since the ligands are poorly soluble in DMSO-d6, 
suspensions were initially obtained, which turned into clear orange solutions after heating at 70 °C overnight. 
The 1H NMR spectra of the solutions showed broad and not very well defined peaks, which is not unusual for 
large cage complexes in a viscous solvent.[32, 33, 47, 110] Processing the data of the 1H DOSY NMR also posed 
some problems related to the broad and overlapping peaks. Nonetheless, the DOSY spectra did confirm the 
formation of complexes with a uniform diffusion coefficient. 
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Figure 4.1. Molecular structures of the ligands L4.1 (left) and L4.2 (right) as determined by single crystal X-ray 
diffraction. Hydrogen atoms and solvent molecules are omitted for clarity. Grey: C; blue: N; green: B; red: O; 
and orange: Fe. 
 
 
Scheme 4.2. Synthesis of the coordination cages 4.1 and 4.2. 
 
For both reactions, clear evidence for the formation of PdII6L8-type complexes was obtained by mass 
spectrometry. The MS analyses were performed on a hybrid LTQ Orbitrap FTMS instrument operated in the 
positive ionization mode. The HESI-II probe in an Ion Max ion source was in-house modified in order to perform 
cold-spray ionization (CSI), a variant of electrospray ionization operated at low temperature.[111] For more 
details about this method and the set-up can be found in the experimental section of this thesis. CSI-MS can 
be used to prevent decomposition of labile supramolecular structures and was shown to be crucial for such 
measurements. Using this methodology, the major peaks observed in the 1200–2600 m/z mass range were 
attributed to [PdII6L8]12+ complexes with a variable number of BF4– anions (Figure 4.2 and 4.3). 
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Figure 4.2. CSI-HRMS of cage 4.1 in 10% DMSO-d6 in CH3CN (left) and on the right a zoom-in of the 12+ 
charged peak around 1255 m/z in the HRMS spectrum of coordination cage 4.1 in CH3CN (bottom), with 
simulated spectrum shown in dashed lines above. 
 
 
Figure 4.3. CSI-HRMS of cage 4.2 in 10% DMSO-d6 in CH3CN (left) and on the right a zoom-in of the 12+ 
charged peak around 1407 m/z in the HRMS spectrum of coordination cage 4.2 in CH3CN (bottom), with 
simulated spectrum shown in dashed lines above. 
Cage 4.1 was characterized by single crystal X-ray diffraction, and graphic representations of the cationic 
[PdII6(L4.1)8]12+ complex are depicted in Figure 4.4. The location of most anions and solvent molecules is ill 
defined in the electron density map, and the solvent-masking program in OLEX2 was applied to treat this 
disorder.[112] 
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Figure 4.4. Molecular structure of cage 4.1 as determined by single crystal X-ray diffraction. Hydrogen atoms, 
BF4– anions, and solvent molecules are omitted for clarity. Grey: C; blue: N; green: B; red: O; cyan: Pd and 
orange: Fe. 
The six PdII ions are positioned at the vertices of an octahedron, and the ligands panel the eight faces. The 
maximum Pd···Pd distance is 3.3 nm. This value is larger than what is found for other M6Ln cages (M = PdII, PtII) 
reported in the Cambridge Crystallographic Data Center (CCDC). For an extensive search in the CCDC database, 
the software ConQuest was used with a CCDC database input which was updated on February 2018. The search 
query that was created was MN4 (a metal center surrounded by 4 N-atoms) and MN2P2 (a metal center 
surrounded by 2 N-atoms and 2 P-atoms), with M = PdII or PtII and requirements for the overall molecular 
formula M>1, N>3 and C>40. For all relevant crystal structures returned by this search (676 in total 138 with 
Pt vs 538 with Pd) the indication the max M-M distance was determined, which is indicated by “size” in 
Figure 4.5. The database analysis reveals that the majority of the structures have maximum Pd···Pd distances 
below 2 nm, (Figure 4.5, left) and only few assemblies (amongst which cage 4.1) have a “size” of more than 
3 nm.  
  
Figure 4.5. Graphical representations of a CCDC analysis of supramolecular complexes containing PdII. Left: all 
complexes with M=PdII. Right: all complexes with 6 metals (M) with M = PdII or PtII. Cage 4.1 (maximum Pd···Pd 
distance of 3.3 nm ) was included for the construction of the graphs in red.  
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Cage 4.1 features relatively small openings, because the bulky side chains of the clathrochelate complexes are 
in close proximity to each other. For the calculations of the size of the cavity, by the use of the VOIDOO software 
after removal of solvents and anions. A virtual probe with a radius of 3.0 Å, instead of the standard 1.4 Å probe 
size, was used, which is the smallest probe-size where the probe didn’t fall out of the main cavity. The size of 
the cavity which is accessible by this probe, is estimated to be around 2.8 x 103 Å3 (Figure 4.6). 
 
 
Figure 4.6. Graphical representation of the VOIDOO calculations on cages 4.1, showing the detected void in 
the crystal structures. With the solvent molecules removed from the structure before calculation and the 
calculated void space indicated in green. Grey: C; blue: N; green: B; red: O; cyan: Pd and orange: Fe. 
 
Single crystals for the larger cage 4.2 were also obtained. Unfortunately, we were not able to obtain diffraction 
data of good quality, despite testing different crystals and various experimental set-ups (including synchrotron 
radiation). On two occasions, it was possible to determine the size of the unit cell (~ 193’000 Å3, see 
experimental section), but we were not able to solve the structure. 
In order to estimate the size of cage 4.2, we have constructed a molecular model using the Spartan software. 
The results show that the maximum Pd···Pd distance for this cage is around 4.2 nm. As expected, the cage 
shows much larger openings compared to what was found for 4.1 (Figure 4.7). 
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Figure 4.7. Space filling representation of cage 4.1 (left), as determined by X-ray diffraction, and of cage 4.2 
(right), as obtained by molecular modelling. Solvent molecules are omitted for clarity. Grey: C; blue: N; green: 
B; red: O; cyan: Pd and orange: Fe. 
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4.3 Conclusion 
To conclude, we have investigated if it is possible to inflate coordination cages by increasing the size of the 
ligand. On purpose, we have chosen PdII6L8-type cages for our study. Due to geometric constraints, these 
complexes are not likely to undergo a structural reorganization into smaller aggregates. We have synthesized 
two large, tritopic N-donor ligands by using clathrochelate complexes as key structural elements. Upon 
combination with Pd2+ ions, we were indeed able to form PdII6L8-type coordination cages. One cage was 
characterized by single crystal X-ray diffraction. With a maximum Pd···Pd distance of 3.3 nm, this complex 
represents the largest M6Ln cage (M = PdII, PtII) in the CCDC database. The second cage is even larger (Pd···Pdmax 
~ 4.2 nm), but unfortunately we were not able to obtain diffraction data of sufficient quality to solve the 
structure (despite using synchrotron radiation). This failure is indicative of one key challenge when working 
with metallosupramolecular structures of this size: the structural characterization becomes exceedingly difficult. 
For the present study, we have focused on structural aspects, but it is clear that very large cages offer interesting 
opportunities in terms of function (e.g. encapsulation of large guests).  
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5.1 Introduction 
The relation between the basicity of a ligand and the stability of a metal complex has been investigated by 
Kapinos and Sigel for dicationic metal ions and a series of pyridine ligands.[114] In aqueous solution (25 °C, 
I = 0.5 M NaNO3), they observed that the logarithm of the association constant K is proportional to the pKa 
value of the protonated pyridine ligand (Scheme 5.1a). For 3d transition metal ions and for sterically non-
demanding pyridines (no ortho substituents), they found that the correlation factor m varies between 0.10 
(Mn2+) and 0.42 (Cu2+). The fact that the correlation factor m is significantly smaller than 1 has an interesting 
consequence: Let’s consider two ligands LA and LB, with LB being more basic than LA (Scheme 5.1b). Ligand LB 
will form a more stable complex with M2+. When the two ligands compete for a limiting amount of M2+, complex 
[MII(LB)]2+ will be more abundant than [MII(LA)]2+. However, in the presence of an appropriate amount of acid, 
ligand LB will be protonated first, and [MII(LA)]2+ will be the dominant metal complex in solution. 
 
Scheme 5.1. Correlation between ligand basicity and complex stability. 
We hypothesized that similar trends might be observed in non-aqueous solutions for more complex 
metallosupramolecular assemblies. If this would be the case, then one could use acid to switch between 
different metal-ligand assemblies, in a similar way as it is possible to perform an acid-induced switch from 
[MII(LB)]2+ to [MII(LA)]2+ (Scheme 5.1b). 
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5.2 Results and discussion  
For our studies, we focused on supramolecular structures containing Pd2+ ions and polydentate N-donor 
ligands. As discussed in Chapter 1, these kinds of complexes have been studied extensively over the last years, 
and applications in the fields of catalysis,[115] medicinal chemistry,[19f-19h, 116] and materials science[5f, 117] are 
currently being investigated. 
There is evidence that the ligand basicity is an important factor for the stability of [PdIIn(N-donor)m]2n+ 
assemblies. Mukherjee and co-workers have shown that a [PdII2L4]4+ complex based on a ditopic pyridyl ligand 
can be converted into a macrocyclic [PdII3L’6]4+ complex or a spherical [PdII6L’’8]12+ cage by addition of more 
basic imidazolyl ligands, which displace the pyridyl ligands.[45] Furthermore, it was demonstrated by the groups 
of Hardie,[109a] Chand,[118] and Crowley[19a] that 4-dimethylaminopyridine (DMAP) can be used to convert 
[Pd6L8]12+ and [PdII2L4]4+ structures into the more stable [PdII(DMAP)4]2+, and that the disassembly process can 
be reversed by addition of p-toluenesulfonic acid. The latter reactions represent a more complex version of the 
system depicted in Scheme 5.1b. However, it should be noted DMAP is a highly basic N-donor ligand. In 
acetonitrile, the pKa of the corresponding acid is more than 5 units higher than that of protonated pyridine 
(17.95 vs. 12.53, respectively).[119] The ligands which are typically used for the construction of 
[PdIIn(N-donor)m]2n+ assemblies are significantly less basic than DMAP, and it was not clear how the stability of 
PdII complexes is affected by more subtle changes in ligand basicity. 
Figure 5.1a depicts the ditopic N-donor ligands which we have employed for our studies. The bent bipyridyl 
ligand L5.1 is known to form [PdII2(L5.1)4]4+ complexes,[120] whereas the linear ligand L5.2 gives tetrahedral 
[Pd4(L5.2)8]8+complexes[24, 25c] upon combination with Pd2+. The ligands L5.3 and L5.4 contain electron-
donating methoxy groups in para position to the N-donor atom. Therefore, they represent more basic 
analogues of L5.1 and L5.2. For comparison, the pKa values of pyridine and p-methoxypyridine in acetonitrile 
differ by 1.7 units (12.53 vs 14.23, respectively).[119] When mixed with [Pd(CH3CN)4](BF4)2, ligand L5.3 was found 
to give a dinuclear [PdII2(L5.3)4]4+ complex, similar to what was observed for L5.1. For the linear ligand L5.4, 
we observed the clean formation of a double-walled [PdII3(L5.4)6]6+ macrocycle instead of a tetrahedral cage 
as observed for L5.2. The reason for the preferential formation of a [PdII3L6]6+ complex instead of a [PdII4L8]8+ 
complex is presently not clear. However, it should be noted that [PdII3L6]6 and [PdII4L8]8+ (tetrahedral or 
macrocyclic) complexes seem to be similar in energy, and small changes can trigger an interconversion as 
discussed in Chapter 1. 
It is worth noting that trinuclear [PdII3L6]6+ complexes and tetrahedral [PdII4L8]8+ structures can easily be 
distinguished by NMR spectroscopy, because the latter have a reduced symmetry (double set of signals for the 
ligands). The new complexes [PdII2(L5.3)4]4+ and [PdII3(L5.4)6]6+ were also characterized by high-resolution mass 
spectrometry. The metalloligand L5.5 contains a chemically inert Fe2+ clathrochelate complex.[1] The reaction 
of L5.5 with Pd2+ is known to give an octahedral [PdII6(L5.5)12]12+ complex.[78] 
The relative basicity of the ligands L5.1–L5.5 was determined by NMR spectroscopy. For this purpose, we have 
performed titration experiments with pairs of ligands and trifluoroacetic acid (TFA) in either CD3CN or a 1:1 
mixture of CD3CN and CD2Cl2 (L5.4 and L5.5 are poorly soluble in pure CD3CN). Since it was not possible to 
use a common solvent for all ligands, we have not attempted to obtain quantitative values. The simple 
monodentate ligands DMAP, 4-methoxypyridine (MeOPy), pyridine (Py), and 3-chloropyridine (ClPy) were 
included as references (Figure 5.1b). 
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Figure 5.1. a) Structures of the N-donor ligands used in this study and the corresponding complexes with Pd2+; 
b) The relative basicity of the ligands. The pKa values (acetonitrile) of the pyridine reference compounds are 
taken from reference 119. 
The ligands L5.1–L5.3 were found to be more basic than 3-chloropyridine but less basic than pyridine, with 
L5.1 being the least basic of the three, and L5.2 and L5.3 displaying comparable basicity. Ligand L5.4 has 
similar basicity to 4-methoxypyridine, but it is less basic than the metalloligand L5.5. The high basicity of the 
latter can be attributed to the presence of a tetra-coordinated boronate ester group.[121] Still, L5.5 was found 
to be significantly less basic than DMAP. 
The donor strength of the ligands was evaluated by determining the Huynh Electronic Parameter (HEP).[122] In 
order to do so, we have prepared PdII complexes featuring an N-heterocyclic carbene ligand in trans position 
to the N-donor (Figure 5.2). Solutions of the complexes in CDCl3 were analyzed by 13C NMR spectroscopy. The 
HEP corresponds to the chemical shift of the carbene C-atom. The value provides a quantitative measure for 
the σ-donor strength of a ligand, with higher numbers indicating a better donor capability. The values for L5.1–
L5.5 are given in Table 5.1. It is evident that there is a good match with the relative basicity of the ligands, 
with both the HEP values and the basicity increasing in the order L5.1 < L5.2 ~ L5.3 < L5.4 < L5.5. The HEPs 
of the reference compounds are aligned accordingly: the lowest value is found for 3-chloropyridine (158.7), 
followed by pyridine (160.1),[123] 4-methoxypyridine (160.5), and finally DMAP (162.1). 
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Scheme 5.2. Reaction between the dimeric carbene complex and an N-donor ligand for determining the HEP. 
Next, we have examined the relative stability of the PdII assemblies derived from L5.1–L5.5 by performing 
competition experiments with pyridine. Solutions of the five complexes were prepared by dissolving an 
appropriate amount of [Pd(CH3CN)4](BF4)2 together with the corresponding ligand ([L5.x] = 9.0 mM) in a 
mixture of CD3CN and CD3NO2 (8:2). Addition of one equivalent of pyridine-d5, with respect to each N-donor 
atom in the assembly, resulted in partial destruction of the assembly. The extent of pyridine-induced 
disassembly after an equilibration time of 2 h at 60 °C was determined by 1H NMR spectroscopy (Table 5.1 
and Figure 5.2). 
Table 5.1. Disassembly of the PdII complexes upon addition of TFA (4 eq.) or pyridine-d5 (1 eq.), and the HEP 
values of the ligands.a 
L# Assembly Disassembly (%) 
TFA 
Disassembly (%) 
pyridine-d5 
HEP 
(ppm) 
L5.1 [PdII2(L5.1)4]4+ <5 68 159.4 
L5.2 [PdII4(L5.2)8]8+ 44 20 159.8 
L5.3 [PdII2(L5.3)4]4+ 49 29 159.8 
L5.4 [PdII3(L5.4)6]6+ 65 <5 160.4 
L5.5 [PdII6(L5.5)12]12+ >90 <5 161.4 
a The disassembly experiments were performed in CD3CN and CD3NO2 (8:2), whereas the HEP values were 
determined in CDCl3. 
 
Figure 5.2. A graphical representation of the disassembly data represented in Table 5.1.  
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The addition of pyridine had the largest effect on the dinuclear complex [PdII2(L5.1)4]4+, with 68% of the 
assembly being broken, as determined by integration of the 1H NMR cage signals with respect to an internal 
standard (TMS). Significantly smaller values of 20 and 29% were observed for [PdII4(L5.2)8]8+ and for 
[PdII2(L5.3)4]4+, and no significant disassembly was detected for [PdII3(L5.4)6]6+ and [PdII6(L5.5)12]12+ (below 5%). 
One can observe a correlation between the stability of the assembly and the basicity/σ-donor strength of the 
N-donor, with more donating ligands leading to more stable assemblies. It is noteworthy that entropy is 
apparently a less important factor for the stability, because the hexanuclear complex [PdII6(L5.5)12]12+ is 
significantly more stable than the entropically favored dinuclear complexes [PdII2(L5.1)4]4+ and [PdII2(L5.3)4]4+. 
The acid resistance of the PdII complexes was determined in a similar fashion using TFA (4 eq. with respect to 
the amount of N-donor atoms) instead of pyridine. Now, the correlation between stability and ligand basicity 
was inversed: the hexanuclear complex [Pd6(L5.5)12]12+ was found to be the most acid-sensitive assembly 
(nearly full disassembly), and extended acid resistance was observed for the dinuclear complex [PdII2(L5.1)4]4+ 
(Table 5.1).  
The results of the competition experiments suggested that an acid-induced switch between different 
[PdIInL2n]2n+ structures could be possible.[9c, 82j, 124] First, we examined the conversion of the most acid-sensitive 
assembly [PdII6(L5.5)12]12+ into the most acid-resistant assembly [PdII2(L5.1)4]4+ (Scheme 5.3a). A prerequisite 
for such a switch is the structural integrity of [PdII6(L5.5)12]12+ in the presence of an excess of L5.1. The superior 
stability of [Pd6(L5)12]12+ suggested that the octahedral cage might be the preferred assembly in a competition 
situation with L5.1. When an equilibrated solution of L5.1 (2 eq.), L5.5 (2 eq.) and [Pd(CH3CN)4](BF4)2 (1 eq.) in 
CD3CN/CD3NO2 (8:2) was analyzed by 1H NMR spectroscopy, we indeed observed the selective formation of 
[PdII6(L5.5)12]12+ along with 'free' ligand L5.1 (Scheme 5.4). When TFA (4 eq.) was added to the mixture, we 
could observe the interconversion of the octahedral cage into the dinuclear complex [Pd II2(L5.1)4]4+. After an 
equilibration time of 2 h at 60 °C, the transformation of [PdII6(L5.5)12]12+ into [PdII2(L5.1)4]4+ was complete 
(> 90% according to 1H NMR, Scheme 5.4).  
 
 
Scheme 5.3. Acid-induced interconversion of different [PdIInL2n]2n+  
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Scheme 5.4. Aromatic part of the 1H NMR spectra (400 MHz, CD3CN/CD3NO2 8:2) of a mixture of 
[Pd(CH3CN)4](BF4)2 (1 eq.), ligand L5.1 (2 eq.), and ligand L5.5 (2 eq.) before (spectrum on the bottom) and 
after (spectrum directly above) addition of the TFA (2 eq. per pyridine group present). The relevant reference 
spectra are shown above.  
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An acid-induced interconversion of [PdIInL2n]2n+ structures was also possible for the ligand pairs L5.5/L5.2 and 
L5.4/L5.1. In the former case, ligand exchange transformed an octahedral cage into a tetrahedral cage 
(Scheme 5.5), whereas in the latter case, a double-walled triangle was converted into a dinuclear cage structure 
(Scheme 5.6). 
 
 
Scheme 5.5. Aromatic part of the 1H NMR spectra (400 MHz, CD3CN/CD3NO2 8:2) of a mixture of 
[Pd(CH3CN)4](BF4)2 (1 eq.), ligand L5.2 (2 eq.), and ligand L5.5 (2 eq.) before (spectrum on the bottom) and 
after (spectrum directly above) addition of the TFA (2 eq. per pyridine group present). The relevant reference 
spectra are shown above.  
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Scheme 5.6. Aromatic part of the 1H NMR spectra (400 MHz, CD3CN/CD3NO2 8:2) of a mixture of 
[Pd(CH3CN)4](BF4)2 (1 eq.), ligand L5.1 (2 eq.), and ligand L5.4 (2 eq.) before (spectrum on the bottom) and 
after (spectrum directly above) addition of the TFA (2 eq. per pyridine group present). The relevant reference 
spectra are shown above. 
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Furthermore, we examined the behavior of a mixture containing L5.2 and L5.3 (Scheme 5.3d). These ligands 
display a comparable basicity and, according to the HEP, the same σ-donor strength (Table 5.1). When 
combined with [Pd(CH3CN)4](BF4)2, the 1H NMR spectrum showed the preferential formation of the entropically 
favored dinuclear complex [PdII2(L5.3)4]4+, but small amounts of the tetramer [PdII4(L5.2)8]8+ could also be 
detected. No ligand scrambling was observed by 1H NMR or MS. Upon addition of acid, the relative abundance 
was inversed, with [PdII4(L5.2)8]8+ being the dominant metal-ligand assembly in solution (Scheme 5.7). These 
results show that even small differences in ligand basicity can be exploited to generate a large bias in the 
structures expressed by self-assembly. Other ligand combinations like L5.1/L3 and L5.2/L5.4 were also tested, 
but ligand scrambling was observed, and more detailed investigations were therefore not performed. 
 
 
 
Scheme 5.7. Aromatic part of the 1H NMR spectra (400 MHz, CD3CN/CD3NO2 8:2) of a mixture of 
[Pd(CH3CN)4](BF4)2 (1 eq.), ligand L5.2 (2 eq.), and ligand L5.3 (2 eq.) before (spectrum on the bottom) and 
after (spectrum directly above) addition of the TFA (2 eq. per pyridine group present). The relevant reference 
spectra are shown above. As can be observed there is no complete self-sorting or switching in this case; the 
description on the left side indicates the major species in solution.  
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5.3 Conclusion 
In summary, we have investigated the stability of five different [PdIIn(N-donor)2n]2n+ assemblies (four cages and 
one macrocycle) by performing disassembly experiments with pyridine and TFA. The susceptibility towards 
degradation by pyridine was found to be inversely correlated to the acid resistance. The most acid-resistant 
complex [PdII2(L5.1)4]4+ was disassembled to a large extent upon addition of pyridine (68%), whereas the most 
pyridine-resistant cage [PdII6(L5.5)12]12+ was very sensitive to acid. The contrasting behaviour upon addition of 
pyridine or TFA, can be linked to the basicity of the N-donor ligand. Interestingly, ligand basicity seems to be 
a more dominant factor for the stability of the assembly than entropy. For example, we observed the selective 
formation of the hexanuclear cage [PdII6(L5.5)12]12+ in the presence of L5.1, even though L5.1 can form the 
entropically favored dinuclear [PdII2(L5.1)4]4+ complexes.  
The context-dependent stability of PdII-based metal-ligand assemblies should be considered for applications 
of these complexes as drug delivery systems, as cages based on highly basic ligands are expected to be more 
resistant to detrimental ligand exchange reactions with competing bio-ligands. On the other hand, these cages 
would be more susceptible to releasing their ‘cargo’ under the more acidic conditions of a tumor cell.[125] The 
possibility to use the pH for a (reversible) switch between different supramolecular structures could also be of 
interest for application in materials science.[126] Evidently, the stability of metal-ligand assemblies is influenced 
by numerous factors, the ligand basicity/donor strength being just one of them. Therefore, it will be interesting 
to investigate if an inverse correlation between acid and pyridine resistance can be observed for 
metallosupramolecular structures other than [PdIInL2n]2n+ complexes. 
 
 
 
 
 
 -55- 
 Reversible disassembly of 
metallosupramolecular structures mediated 
by a metastable-state photoacid 
This chapter is based on published work: 
“Reversible disassembly of metallosupramolecular structures mediated by a metastable-state photoacid”[127] 
S. M. Jansze, G. Cecot, K. Severin, Chemical Science 2018, 9, 4253-4257. 
Reprinted in an adapted version with permission from the Royal Society of Chemistry and all authors. 
S. M. Jansze has contributed by designing and performing experiments, writing text and constructing figures 
for this publication. 
 
  
Reversible disassembly of metallosupramolecular structures mediated by a metastable-state photoacid 
-56- 
6.1 Introduction 
The controlled manipulation of supramolecular structures with light represents an interesting option to create 
functional nanoscale devices.[124, 128] A common strategy to implement light-responsiveness in metal-ligand 
assemblies is the utilization of photochromic ligands. Light allows altering the geometry of the ligand, which in 
turn may result in a structural reconfiguration of the metallasupramolecular assembly.[5c, 9c] For example, 
bipyridyl ligands containing dithienylethene units have been used for the light-induced conversion of a PdII24L48 
capsule into small metallamacrocycles,[129] to create PdII2L4 cages with light-dependent host-guest chemistry,[21] 
and for the photo-induced sol-gel switching of a metallogel.[130] Ligands containing the azobenzene motif were 
employed to modulate the host-guest chemistry of a spherical PdII12L24 complex,[37] to alter the solubility of a 
coordination cage,[131] and to control the catenation of a palladium metallacycle.[132] 
The construction of light-responsive metal-ligand assemblies with photochromic ligands is not straightforward. 
The design of suited ligands can be challenging, and the preparation of the ligands may involve substantial 
synthetic efforts. In this study, we describe an alternative and more general approach to render metal-ligand 
assemblies light-responsive: the addition of a metastable-state photoacid. Based on the knowledge presented 
in the previous chapter, we demonstrate that the acidification by the photoacid upon irradiation can be used 
for the disassembly of for the switching between metallasupramolecular structures.[49, 133] The process is 
reversible, and the original metallasupramolecular structures form again in the dark at room temperature 
(Scheme 6.1). 
 
 
Scheme 6.1. Reversible disassembly of metallasupramolecular structures by means of a metastable-state 
photoacid (PAH). The M6L12 coordination cage is used as a representative example of a metal-ligand assembly 
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6.2 Results and Discussion  
For our investigations, we decided to use the merocyanine photoacid PAH, the structure of which is depicted 
in Scheme 6.2. Upon exposure to violet light (425 nm), PAH undergoes a ring-closing reaction to give the 
spiropyran PA– , along with liberation of a proton (Scheme 6.2).[134] The spiropyran form is metastable and 
accumulates under irradiation. As a result, a pH drop of more than 2 units can be achieved. When light 
irradiation is stopped, the merocyanine form PAH is regenerated. 
 
Scheme 6.2. Irradiation with light converts the merocyanine PAH into the spiropyran PA–, with concomitant 
liberation of a proton. 
The metastable-state photoacid PAH was introduced by Liao and co-workers in 2011.[135] Since then, PAH and 
structurally related compounds have been used in the context of supramolecular chemistry. Applications 
include the light-induced complexation of a pyridinium salt by a macrocyclic receptor,[136] the switching of a 
rotaxane-based molecular shuttle,[137] the light-controlled reversible self-assembly of nanorods,[138] the 
reversible chromism of guests in coordination cages,[139] the modulation of a hydrazine switch,[140] the reversible 
photo-induced gel-sol transition of a dipeptide gel,[141] and the controlled aggregation of nanoparticles,[142] 
among others.[143, 134] We wanted to explore if PAH is also suited for controlling the structures of metal-ligand 
assemblies by light. 
 
 
Figure 6.1. Chemical structures of model complexes 6.1–6.4. 
First, we performed test reactions with the PdII complex [(dppp)Pd(py)2](OTf)2 (6.1). Complex 6.1 features a 
strongly bond 1,3-bis(diphenylphosphino)propane (dppp) ligand and two labile pyridine (py) ligands 
(Figure 6.1). We chose complex 6.1, because PdII complexes with chelating diphosphine ligands are popular 
building blocks in metallasupramolecular chemistry.[9a, 9b] As connecting units, polypyridyl ligands are often 
employed, and the pyridyl ligands in 6.1 are surrogates for more intricate ligands. A solution of complex 6.1 
(125 µM) and PAH (8 equiv.) was prepared in the dark using a mixture of CD3CN and D2O (8:2) as the solvent. 
The solution was then irradiated for 20 minutes with violet light using a commercial LED panel (λ = 425 nm). 
After irradiation, the sample was immediately analyzed by 1H and 31P NMR spectroscopy, and further NMR 
spectra were recorded after 8 hours in the dark (Scheme 6.3). 
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The 1H NMR spectrum of the mixture before irradiation shows two doublets in the region between 7.5 and 
9 ppm, which can be assigned to the photoacid PAH (Scheme 6.3, left side). In addition, one can observe a 
doublet at ~ 8.5 ppm, resulting from the pyridine NCH protons. Irradiation leads to the nearly complete 
disappearance of the two PAH signals. The NCH signal of the bound pyridine ligands is no longer observable. 
Instead, three new signals appear. These peaks can be attributed to the formation of protonated pyridine 
(6.1b), as evidenced by comparison with a reference sample of pyridinium chloride (Scheme 6.3, spectrum on 
the top left side). After 8 hours in the dark, the NMR spectrum of the sample is indistinguishable from that of 
the sample before irradiation. The 31P NMR spectrum of the starting mixture shows a broad peak at ~ 9 ppm, 
which is converted to a sharper signal at ~ 12 ppm after irradiation (Scheme 6.3, right side). A similar signal is 
observed when complex [(dppp)Pd](OTf)2 is dissolved in CD3CN/D2O. We attribute this signal to a complex 
[(dppp)PdIIL2] (6.1a), with L being either solvent and/or triflate. Again, the spectrum converts back to that of 
the starting mixture when the sample is kept in the dark. Taken together, the data are strong evidence for a 
light-induced displacement of the pyridine ligands, which is fully reversed in the dark. 
 
Scheme 6.3. Irradiation of a mixture of complex 6.1 (125 µM) and the photoacid PAH (8 equiv.) in CD3CN/D2O 
(8:2) by violet light results in the displacement of the pyridyl ligands as evidenced by the 1H NMR (left side) 
and 31P NMR spectra (right side). The triflate anions of 6.1 are not shown for clarity. L indicates solvent or OTf– . 
Similar test reactions were performed with the model complexes [(py)4PdII](BF4)2 (6.2), [(bipy)3FeII](BF4)2 (6.3), 
and [(bipy)3ZnII](BF4)2 (6.4) (bipy = 2,2’-bipyridyl) (Figure 6.1). These kind of coordination motifs are also found 
in numerous metallasupramolecular assemblies.[10d, 15, 17a, 144] As it was observed for 6.1, it was possible to 
dissociate the N-donor ligands by irradiation with light, and re-complexation was observed in the dark.[127] For 
the PdII complex 6.2 and the ZnII complex 6.4, the photo-induced conversion was very high (> 80%), whereas 
for the FeII complex 6.3, only partial disassembly was observed (~ 46% of complex 6.3 remained intact). We 
have also attempted to break complex 6.3 with a Brønsted acid, namely trifluoroacetic acid (TFA, 4 equiv. with 
respect to the N-donor groups). As with PAH, only partial disassembly was observed, indicating that the FeII 
complex is less susceptible to an acid-induced ligand displacement. 
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Figure 6.2. Structures of the pyridyl ligands 6A–6F. 
Encouraged by the results with the model complexes 6.1–6.4, we next examined reactions with larger and 
structurally more complex metal-ligand assemblies. Six different metallasupramolecular structures were 
prepared using the pyridyl ligands depicted in Figure 6.2. More specifically, we have prepared an octahedral 
PdII6L12 cage with [PdII (py*)4]2+ (py* = substituted pyridine) complexes at the vertices, bridging ligands 6A, and 
a [B(p-C6H4F)4]– guest molecule (6.5),[78] two MII6L4 cages with gyrobifastigium-like geometry and 
[(dppp)PdII(py*)]2+ or [(dcpm)PtII(py*)]2+ complexes connecting the tetratopic ligand 6C (6.6 and 6.7, dcpm = 
bis(dicyclohexylphosphino)methane),[66b, 80a] a coordination barrel containing [(dcpm)PtII(py*)]2+ complexes and 
ligand 6D (6.8),[80a] a trigonal prismatic Ru complex with trispyridyl ligand 6E (6.9), and an PdII2L4 cage based 
on ligand 6F with [PdII(py*)4]2+ vertices (6.10)26 (Figure 6.3). 
First test reactions with complex 6.5 and TFA (2 equivalences to N-donor) showed that the complex can be 
fully disassembled by acid. We then set up an experiment similar to what has been described for the model 
complexes. Assembly 6.5 was dissolved together with an excess of the photoacid PAH in a mixture of CD3CN 
and D2O (8:2) in the dark. After irradiation with violet light, we immediately recorded 1H and 19F NMR spectra, 
followed by additional spectra after a waiting period of 8 hours in the dark. Preliminary studies revealed that 
the addition of small amounts of NaCl facilitated the disassembly process, and all subsequent experiments with 
6.5 were performed with six equivalents of NaCl. It is worth noting that chloride ions are known for their ability 
to decompose PdII cages.[19a, 145, 42] For complex 6.5, six equivalents of NaCl were not sufficient to induce 
detectable decomposition, even though we were able to disrupt the assembly at higher NaCl concentrations. 
The beneficial effect of small amounts of NaCl for the photoswitching process might be due to stabilization of 
the PdII ions after ligand displacement. 
The 1H NMR spectrum after irradiation indicates the acid-induced de-complexation of the pyridyl ligands 
(Scheme 6.4, left side). Additional evidence for the disassembly of the octahedron was obtained by analyzing 
the 19F NMR spectra (Scheme 6.4, right side). The initial spectrum shows two signals, one for the encapsulated 
[B(p-C6H4F)4]– guest molecule, and one for non-bound [B(p-C6H4F)4]–. After irradiation, only ‘free’ [B(p-C6H4F)4]– 
(6.5c) is observed. In the dark, the PdII6L12 cage is re-formed, as corroborated by the 1H NMR spectrum, and 
the 19F NMR signal of the encapsulated borate anion. Overall, it is evident that light irradiation leads to a 
destruction of the metallasupramolecular structure and liberation of the guest. The process is reversible: in the 
dark, the cage with the encapsulated guest is formed again.  
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Figure 6.3. Schematic representation of the metallasupramolecular structures used in this study.  
 
Experiments with the assemblies 6.6–6.10 gave similar results: a reversible, light-induced disassembly of the 
cage structures was observed by NMR spectroscopy in all cases.[127] For 6.6, 6.7, and 6.8, the switching 
efficiency was found to be very high, with at least 80% of the cages being disassembled by the photoacid. For 
6.9 and 6.10, the process was less efficient, with only 16% (6.9) and 45% (6.10) of the cage structures being 
disrupted. 
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Scheme 6.4. Irradiation of a mixture of cage 6.5 (10 µM), NaCl (60 µM), and the photoacid PAH (8 equiv. with 
respect to each bipyridyl ligand) in CD3CN/D2O (8:2) by violet light results in disassembly of the cage and 
liberation of the [B(p-C6H4F)4]– guest (green ball) as evidenced by the 1H NMR (left) and 19F NMR spectra (right). 
Details about the bridging ligand (yellow) are given in the ESI. 
The difference in switching efficiency between cage 6.5 (> 80%) and cage 6.10 (45%) is intriguing, given that 
both assemblies are based on [PdII(py*)4]2+ complexes. We were able to identify two factors which contribute 
to the reduced switching efficiency observed for 6.10: First, 1H NMR spectrometry revealed the photoacid binds 
weakly to cage 6.10,[146, 18d, 127] and this interaction is expected to stabilize the assembly. Such an interaction 
was not observed for cage 5. Second, as also described in the previous chapter, the pyridyl ligand 6A used for 
cage 6.5 is more basic than the pyridyl ligand 6F used for cage 6.10. Consequently, acid-induced disassembly 
is favored for cage 6.5.  
The disassembly process was fully reversible in all cases. Kinetic investigations at 298 K showed that all 
assemblies are re-formed with half-lifes between 20 and 70 minutes. For comparison: the photoacid alone 
switches back with t1/2 of 2.4 minutes under these conditions (CH3CN/H2O, 8:2), indicating that the re-formation 
of the coordination complex is the rate-limiting step. The re-assembly of the complexes 6.5 and 6.8 was also 
followed at 50 °C. As expected, the reactions were faster, and complete re-assembly was observed after 30 
minutes (6.5) or 10 minutes (6.8), respectively. 
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The robustness of the photoswitching process was demonstrated by repeated disassembly-assembly cycles 
using the coordination barrel 6.8 (Figure 6.4). A mixture of the barrel and PAH was irradiated for 20 minutes, 
and then 1H NMR and 31P NMR spectra were recorded. After 2.5 hours in the dark, additional spectra were 
measured. This procedure was repeated another four times. The 1H and 31P NMR spectra show barrel 
destruction and re-assembly over all cycles. The relative amount of the protonated ligand 6.8b, as determined 
by 1H NMR spectroscopy, was used as an indication of the switching efficiency. The process displayed good 
stability over the five cycles (Figure 6.4). Ultimately, the sensitivity of PAH towards hydrolytic degradation 
represents a limit,[135-136] but within the timeframe of our experiment, hydrolysis was not observed. 
 
Figure 6.4. Repeated photoswitching between the coordination barrel 6.8 and its disassembled state. The 
relative amount of the protonated ligand 6.8b was used as an indication of the switching efficiency. For the 
first cycle, the amount of 6.8b was normalized to 0 and 100%, respectively. 
 
In view of the results summarized above and in the previous chapter, we were also interested to explore if PAH 
can also be employed to switch between different [PdIInL2n]2n+ structures.  
As a test reaction, we have examined the acid-induced conversion of [Pd6(6B)12]12+ into [PdII2(6F)4]4+.[113] A 
solution containing 6B (2 eq.), 6F (2 eq.) and [PdII(CH3CN)4](BF4)2 (1 eq.) in CD3CN/D2O (8:2) was prepared. The 
photoacid PAH (2 eq. per N-donor) was added in the dark, and the mixture was analyzed by 1H NMR 
spectroscopy. Exposing the sample to violet light at room temperature for 11 h lead to conversion of 
[PdII6(6B)12]12+ into [PdII2(6F)4]4+ (Scheme 6.5). The reaction could be reversed by keeping the sample in the 
dark at 60 °C for 6 h. Over the course of the reaction, the photoacid is hydrolyzed to a small extent. Therefore, 
this methodology is not suited to repetitive switching between different structures. Nevertheless, it shows that 
the interconversions of [PdIInL2n]2n+ complexes can be triggered by light. 
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Scheme 6.5. 1H NMR (400 MHz) spectra of the switching between [PdII6(6B)12]12+ (bottom) and [PdII2(6F)4]4+ 
(one up from the bottom) and back (two up from the bottom) by the addition of 2 eq. of PA in a mixture of 
CD3CN and D2O (8:2) and the reference spectra.   
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+ 
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 +4  
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6.3 Conclusion 
We have demonstrated that the addition of a metastable-state photoacid to solutions of 
metallasupramolecular assemblies renders the systems photo-responsive. Irradiation with violet light leads to 
proton transfer from the photoacid to the ligands, resulting in partial or full disassembly of the metal-ligand 
structure. The process is in all cases reversed in the dark. In principle, similar changes could be induced by 
addition of acids and bases, as described in the previous chapter. However, the utilization of light is not 
effecting the overall composition of the system (e.g. no accumulation of salts), and light can be used with good 
spatial and temporal control. Compared to the utilization of photochromic ligands, our approach offers the 
advantage of being more general and easier to implement. For the present study, we have focused on 
metallasupramolecular structures based on polypyridyl ligands, but it is expected that the methodology can 
be extended to assemblies with other ligands, given that the basicity of the system is within the pH range of 
the photoacid. We have already shown that the approach is suited for the light-induced release of guest 
molecules, but other applications can be envisioned as well. For example, it could be possible to control 
catalytic reactions with light, since some coordination cages are able to act as catalytic nanoreactors.[94c, 94d] 
Furthermore, it should be possible to use a related approach for photoswitching of metallasupramolecular 
polymers and metallogels. 
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 Conclusions and outlook 
To conclude, this thesis has shown the applicability of clathrochelate metalloligands in structural 
supramolecular chemistry. The study of these coordination structures, has given three new insight into 
structural supramolecular chemistry, namely: 1) the importance of ligand size ratio on cage architecture and 
stability, 2) clathrochelates metalloligands are particularly suitable for the formation of large supramolecular 
structures and 3) knowledge into the context-dependent stability of coordination structures.  
The first three research chapters of this thesis describe mainly the results that lead to the first two insights. 
When the aspect ratio of a ligand is reduced, by either decreasing the length or increasing the width of the 
ligand, a structure of higher nuclearity is obtained. These results indicate that the aspect ratio of rigid rod-type 
ligands can be used as a decisive factor in metal-based self-assembly reactions. The employment of large and 
easily accessible double clathrochelate ligands affords PdII2L4-type cages of unprecedented size. Competition 
experiments to study the stability of these cages indicated that the close packing of the lipophilic side chains 
led to increased stability. Finally, triple clathrochelate metalloligands were employed to construct PdII6L8-type 
coordination cages, again unprecedented in size.  
The fifth and sixth chapters of this thesis describe the results that lead to the third insight. A detailed study into 
the basicity and stability of a range of ligands, and the [PdIIn(N-donor)2n]2n coordination structures that form 
from these ligands, shows that more basic ligands give coordination complexes which are more resistant 
against pyridine disassembly. In contrast, the nanostructures based on more basic ligands were more sensitive 
to disassembly upon the addition of acid. This context-dependent stability was used to switch between 
different [PdIIn(N-donor)2n]2n coordination complexes. A metastable-state photoacid was then employed to 
reversibly disassemble a range of supramolecular cage structures.  
Clathrochelate metalloligands were ideally suited for these studies due to the straightforward adaptation of 
length, width and functional groups on the ligands. The clathrochelate metalloligands are prepared in a 
one-pot synthesis from readily accessible starting materials. Besides, studies have shown that clathrochelate 
ligands are particularly basic, and are therefore forming more thermodynamically stable structures. 
By gaining these three insights into structural supramolecular chemistry, it has become possible to better 
understand and predict the coordination complexes that form from ligands with specific properties. This 
implies that the design of even more complex functional nanostructures is within reach. By having the 
possibility to carefully design structures with a certain shape, size or stability, functions like selective 
encapsulation and release of guests can be introduced in a targeted manner. 
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Experimental section 
General 
All chemicals were obtained from commercial sources (see below, per chapter) and used without further 
purification unless stated otherwise. Solvents were dried using a solvent purification system from Innovative 
Technologies, Inc.. Reactions were carried out under an atmosphere of dry N2 using standard Schlenk 
techniques. 
NMR spectra were obtained on a Bruker DRX (1H: 400 MHz) equipped with a BBO 5 mm probe, a Bruker 
Avance III spectrometer (1H: 600 MHz) equipped with a 5 mm CPTCIz cryo-probe, a Bruker Avance II 
(1H: 800 MHz) equipped with a 5 mm CPTCIz cryo-probe, a Bruker DRX (1H: 400 MHz) equipped with a BBO 5 
mm probe and a Bruker Avance III spectrometer (1H: 400 MHz) equipped with a 5 mm BBFO-Plus probe. The 
chemical shifts are reported in parts per million δ (ppm) referenced to the residual solvent signal or an internal 
standard. All spectra were recorded at 298 K, unless stated otherwise. The analysis of NMR spectra was 
performed with MestreNova and for the DOSY analysis the Baysian DOSY transform from MestreNova was 
used.  
Routine ESI-MS data were acquired on a Q-TOF Ultima mass spectrometer (Waters) operated in the positive 
ionization mode and fitted with a standard Z-spray ion source equipped with the Lock-Spray interface. Data 
were processed using the MassLynx 4.1 software.  
Unless stated otherwise, high resolution mass spectra were acquired for pure, pre-synthesized samples of all 
cages and cage mixtures. The analytes were dissolved in methanol or acetonitrile to a final concentration of 
~10-20 μM. The machine used was a linear trap quadrupole Fourier transform ion cyclotron resonance mass 
spectrometer, 10T LTQ FT-ICR MS (Thermo Scientific), equipped with a 2X NADEL cell.[147] Analytes were ionized 
via HESI source in Ion Max housing (Thermo Scientific); heater temperature was set to 0 °C (effective 
temperature 30−50 °C), and the typical flow rate was 10 μL/min. Mass spectra were acquired with a minimum 
resolution setting of 100,000 at 400 m/z. Or hybrid ion trap-Orbitrap Fourier transform mass spectrometer, 
Orbitrap Elite (Thermo Scientific) equipped with a TriVersa Nanomate (Advion) nano-electrospray ionization 
source. Mass spectra were acquired with a minimum resolution setting of 120,000 at 400 m/z. To reduce the 
degree of analyte gas phase reactions leading to side products unrelated to solution phase, the transfer 
capillary temperature was lowered to 50 °C in both instruments. Experimental parameters were controlled via 
standard and advanced data acquisition software. Post-acquisition analysis was performed using vendor 
software, Xcalibur (Thermo Scientific), and ChemCalc (http://www.chemcalc.org/) web tool.[148] 
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Experimental section Chapter 2 
Commercial sources: 5-bromo-pyridine-2-carbaldehyde (A) – Fluorochem, 4-bromoaniline (E) – Fluorochem, 
pyridine-3-boronic acid – Fluorochem, anhydrous iron(II) chloride – Acros, dimethylglyoxime – Apollo Scientific, 
nioxime – ABCR, [Pd(CH3CN)4](BF4)2 – Sigma Aldrich and Fe(OTf)2 – Sigma Aldrich 
 
Synthetic procedures 
Diethyldioxime[149], boronic acids C[87] and G[88] and the iron(II)triflimide (NTf2) salt[150] were prepared according 
to literature procedures.  
 
Scheme ES1. Synthesis of the pyridine carboxaldehyde-terminated clathrochelates CC2.1–CC2.3. (B) 
CH(OMe)3 (3 eq.), p-TsOH (0.02 eq.), dry MeOH, reflux 3h; (C) 1. dry toluene at –78 °C, BuLi 2.4 M in hexanes 
(1.5 eq.),, 2. dry THF, triisopropylborate (1.2 eq.) at –78 °C. 
CC2.1: Anhydrous FeCl2 (97 mg, 0.76 mmol, 1 eq.), dimethylglyoxime (265 mg, 2.28 mmol, 3 eq.) and boronic 
acid C (300 mg, 1.52 mmol, 2 eq.) were dissolved in degassed MeOH (50 mL). The mixture was heated under 
reflux for 4 h. Subsequently, the solvent was removed under reduced pressure. CHCl3 (20 mL) was added, 
filtered, washed with saturated aqueous NaHCO3 (2x 20 mL) and brine (1x 20 mL) and dried (MgSO4), after 
which the solution was concentrated again under reduced pressure. Purification by silica flash chromatography 
(30 x 5 cm, EtOAc, 40-65 μm, 230-400 mesh) gave clathrochelate D-1 (118 mg, 0.16 mmol, 21%).  
1H NMR (400 MHz, CDCl3) δ 8.85 (s, 2H), 7.95 (dd, J = 7.7, 1.7 Hz, 2H), 7.42 (d, J = 7.6 Hz, 2H), 5.41 (s, 2H) 3.33 
(s, 12H), 2.32 (s, 18H). 13C NMR (101 MHz, CDCl3) δ 156.11, 152.52, 152.51, 140.20, 120.27, 104.50, 53.75, 13.46, 
(C-B not detected). HRMS (ESI): m/z calculated for C28H38B2FeN8O10 [M+H]+ 725.2335, found 725.2346. 
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D-1 was divided over six 5 mL microwave vials in small portions (18 mg, 0.03 mmol). To each of the vials, TsOH 
(0.5 mg, 3 µmol, 0.1 eq.), CHCl3 (3.2 mL) and t-BuOH (0.8 mL) was added. The vials were heated by microwave 
irradiation at 140 °C for 4 h. Afterwards, the combined reaction mixtures were washed with sat. NaHCO3 
(3 × 15 mL), dried (MgSO4), and the solvent was removed under reduced pressure. The product was purified 
by silica flash chromatography (30 × 5 cm, EtOAc, 40-65 μm, 230-400 mesh) to give clathrochelate CC2.1 as a 
red powder (from combined six vials: 87 mg, 0.14 mmol, 92%).  
1H NMR (400 MHz, CDCl3) δ 10.12 (s, 2H), 9.07 (s, 2H), 8.17 (d, J = 7.8 Hz, 2H), 7.96 (d, J = 7.6 Hz, 2H), 2.45 (s, 
16H).13C NMR (101 MHz, CDCl3) δ 194.51, 153.73, 153.0, 152.44, 140.52, 121.13, 13.642, (C-B not detected). 
HRMS (ESI): m/z calculated for C24H27B2FeN8O8 [M+H]+ 633.1487, found 633.1497. 
CC2.2: Anhydrous FeCl2 (97 mg, 0.76 mmol, 1 eq.), nioxime (325 mg, 2.28 mmol, 3 eq.) and boronic acid C 
(300 mg, 1.52 mmol, 2 eq.) were dissolved in degassed MeOH (50 mL). The mixture was heated under reflux at 
80 °C for 4 h. Subsequently, the solvent was removed under reduced pressure. CHCl3 (20 mL) was added, the 
mixture was filtered, washed with saturated aqueous NaHCO3 (2 × 20 mL) and brine (1 × 20 mL), and dried 
(MgSO4), after which the solvent was removed under reduced pressure. Purification by silica flash 
chromatography (30 × 5 cm, EtOAc, 40-65 μm, 230-400 mesh) gave clathrochelate D-2 (198 mg, 0.25 mmol, 
33%).  
1H NMR (400 MHz, CDCl3) δ 8.87 (s, 2H), 8.00 (dd, J = 7.7, 1.8 Hz, 2H), 7.49 (dd, J = 7.7, 1.0 Hz, 2H), 5.39 (s, 2H), 
3.42 (s, 12H), 2.92 (s, 12H), 1.81 (s, 12H). 13C NMR (101 MHz, CDCl3) δ 156.51, 153.05, 152.71, 140.51, 120.60, 
104.95, 54.11, 26.69, 22.01, (C-B not detected). HRMS (ESI): m/z calculated for C34H44B2FeN8O10 [M+H]+ 
803.2806, found 803.2805. 
D-2 was divided over five 5 mL microwave vials in small portions (20 mg, 0.03 mmol). To each of the vials, TsOH 
(0.5 mg, 3 µmol, 0.1 eq.), CHCl3 (3.2 mL) and t-BuOH (0.8 mL) was added. The vials were heated by microwave 
irradiation at 140 °C for 4 h. Afterwards, the combined reaction mixtures were washed with sat. NaHCO3 
(3 × 15 mL), dried (MgSO4), and the solvent was removed under reduced pressure. Purification by silica flash 
chromatography (30 × 5 cm, EtOAc, 40-65 μm, 230-400 mesh) gave clathrochelate CC2.2 as a red powder 
(from combined five vials: 83 mg, 0.12 mmol, 93%). 
1H NMR (400 MHz, CDCl3) δ 10.05 (s, 2H), 8.96 (s, 2H), 8.06 (d, J = 7.6 Hz, 2H), 7.86 (d, J = 8.3 Hz, 2H), 2.88 (s, 
12H), 1.77 (s, 12H). 13C NMR (101 MHz, CDCl3) δ 193.32, 152.61, 151.63, 151.2, 139.44, 119.92, 25.34, 20.52, (C-
B not detected). HRMS (ESI): m/z calculated for C30H33B2FeN8O8 [M+H]+ 711.1957, found 711.1968. 
CC2.3: Anhydrous FeCl2 (97 mg, 0.76 mmol, 1 eq.), ethyldioxime (329 mg, 2.28 mmol, 3 eq.) and boronic acid 
C (300 mg, 1.52 mmol, 2 eq.) were dissolved in degassed MeOH (50 mL). The mixture was heated under reflux 
at 80 °C for 4 h. Subsequently, the solvent was removed under reduced pressure. CHCl3 (20 mL) was added, 
the mixture was filtered, washed with saturated aqueous NaHCO3 (2 × 20 mL) and brine (1 × 20 mL), and dried 
(MgSO4), after which the solvent was removed under reduced pressure. Purification by silica flash 
chromatography (30 × 5 cm, EtOAc, 40-65 μm, 230-400 mesh) gave clathrochelate D-3 (176 mg, 0.22 mmol, 
29%).  
1H NMR (400 MHz, CDCl3) δ 8.93 (s, 2H), 8.02 (dd, J = 7.7, 1.7 Hz, 2H), 7.52 (d, J = 8.2 Hz, 2H), 5.40 (s, 2H), 3.46 
(s, 12H), 2.83 (q, J = 7.5 Hz, 12H), 1.17 (t, J = 7.5 Hz, 18H). 13C NMR (101 MHz, CDCl3) δ 158.02, 155.95, 152.64, 
140.02, 120.11, 104.80, 53.87, 20.91, 11.46, (C-B not detected). HRMS (ESI): m/z calculated for C34H51B2FeN8O10 
[M+H]+ 809.3276, found 809.3281. 
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D-3 was divided over seven 5 mL microwave vials in small portions (20 mg, 0.02 mmol). To each of the vials, 
TsOH (0.5 mg, 3 µmol, 0.1 eq.), CHCl3 (3.2 mL) and t-BuOH (0.8 mL) was added. The vials were heated by 
microwave irradiation at 140 °C for 4 h. Afterwards, the combined reaction mixtures were washed with sat. 
NaHCO3 (3 × 15 mL), dried (MgSO4), and the solvent was removed under reduced pressure. Purification by 
silica flash chromatography (30 × 5 cm, EtOAc, 40-65 μm, 230-400 mesh) gave clathrochelate CC2.3 as a red 
powder (from combined five vials: 115 mg, 0.16 mmol, 95%). 
1H NMR (400 MHz, Chloroform-d) δ 10.13 (s, 2H), 9.08 (s, 2H), 8.15 (d, J = 7.6 Hz, 2H), 7.97 (d, J = 7.6 Hz, 2H), 
2.85 (q, J = 7.5 Hz, 12H), 1.19 (t, J = 7.5 Hz, 18H). 13C NMR (101 MHz, CDCl3) δ 194.45, 158.59, 153.71, 152.31, 
140.45, 121.16, 21.13, 11.63, 1.17. (C-B not detected). HRMS (ESI): m/z calculated for C30H38B2FeN8O8 [M+H]+ 
717.2438, found 717.2434 
The NMR spectra for these clathrochelates are included in the supporting information of the publication cited 
under reference 79.  
 
Scheme ES2. Synthesis of the amine-terminated clathrochelates CC2.4 and CC2.5. (F) Benzylbromide (2.1 eq.), 
Na2CO3 (1.5 eq.), DMF at 110 °C overnight;[24] (G) dry THF at –78 °C, BuLi 2.4 M in hexanes (1.2 eq.), 
triisopropylborate (1.8 eq.).[88] 
 
CC2.4: Anhydrous FeCl2 (60 mg, 0.32 mmol, 1 eq.), dimethylglyoxime (165 mg, 0.94 mmol, 3 eq.) and boronic 
acid G (300 mg, 0.63 mmol, 2 eq.) were dissolved in degassed MeOH (50 mL) and heated under reflux at 80 °C 
for 5 h. The reaction mixture was cooled to r.t. and the precipitate was collected after centrifugation (10 min. 
at 4000 rpm), washed with MeOH (15 mL) and dried to give clathrochelate H-4 (186 mg, 0.19 mmol, 60%). 
1H NMR (400 MHz, CD2Cl2) δ 7.59 (d, J = 8.6 Hz, 4H), 7.35 – 7.25 (m, 20H), 6.81 (d, J = 8.7 Hz, 4H), 4.69 (s, 8H), 
2.40 (s, 18H). 13C NMR (101 MHz, CD2Cl2) δ 152.25, 149.14, 139.85, 133.11, 129.04, 127.30, 127.27, 112.46, 55.11, 
13.61, (C-B not detected). HRMS (ESI): m/z calculated for C52H54B2FeN8O6 [M+H]+ 965.3798, found 965.3779. 
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For the deprotection step, the clathrochelate H-4 (162 mg, 0.17 mmol) was combined with 20% Pd/C (17 mg) 
in MeOH (25 mL) and CHCl3 (10 mL), and placed under an atmosphere of H2 and heated to 50 °C for 4 h. The 
reaction mixture was filtered, washed with MeOH (10 mL), and the solvent was removed under reduced 
pressure. CHCl3 (20 mL) was added, filtered, washed with saturated aqueous NaHCO3 (2 × 20 mL) and brine (1 
× 20 mL), dried over MgSO4. The volume of the solution was reduced to 2 mL under reduced pressure, and the 
solution was mixed with pentane (13 mL). The precipitate was collected and washed with diethyl ether (2 × 15 
mL) to give clathrochelate CC2.4 as a red solid (98 mg, 0.16 mmol, 89%). 
1H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 8.1 Hz, 4H), 6.73 (d, J = 8.2 Hz, 4H), 2.41 (s, 18H). 13C NMR (101 MHz, 
CDCl3) δ 151.81, 146.32, 132.94, 114.83, 13.52, (C-B not detected). HRMS (ESI): m/z calculated for 
C24H31B2FeN8O6 [M+H]+ 605.1902, found 605.1909. 
CC2.5: Anhydrous FeCl2 (100 mg, 0.789 mmol, 1 eq.), nioxime (336 mg, 2.36 mmol, 3 eq.) and boronic acid G 
(500 mg, 1.58 mmol, 2 eq.) were dissolved in degassed MeOH (100 mL). The mixture was heated under reflux 
at 80 °C for 5 h. The reaction mixture was cooled to r.t. and the precipitate was collected after centrifugation 
(10 min. at 4000 rpm), washed with MeOH (15 mL) and dried to give clathrochelate H-5 (607 mg, 0.58 mmol, 
74%). 
1H NMR (400 MHz, CD2Cl2) δ 7.41 (d, J = 7.7 Hz, 4H), 7.37 – 7.15 (m, 20H), 6.69 (d, J = 7.8 Hz, 4H), 4.68 (s, 8H), 
2.85 (s, 12H), 1.76 (s, 12H). 13C NMR (101 MHz, CD2Cl2) δ 152.01, 149.19, 139.86, 133.10, 129.05, 127.31, 127.26, 
112.44, 55.08, 26.71, 22.20, (C-B not detected). HRMS (ESI): m/z calculated for C58H60B2FeN8O6 [M+H]+ 
1043.4269, found 1043.4249. 
For the deprotection step, the clathrochelate H-5 (565 mg, 0.542 mmol) was combined with 20% Pd/C (80 mg) 
in MeOH (35 mL) and CHCl3 (20 mL), placed under an atmosphere of H2 and heated to 50 °C for 4 h. The 
reaction mixture was filtered, washed with MeOH (20 mL), and the solvent was removed under reduced 
pressure. CHCl3 (50 mL) was added, filtered, washed with saturated aqeous NaHCO3 (2 × 50 mL) and brine (1 
× 50 mL), dried over MgSO4. The volume of the solution was reduced to 2 mL under reduced pressure, and the 
solution was mixed with pentane (13 mL). The precipitate was collected and washed with diethyl ether (2 × 15 
mL) to give clathrochelate CC2.5 as a red solid (365 mg, 0.537 mmol, 99%).  
1H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 8.3 Hz, 4H), 6.68 (d, J = 8.3 Hz, 4H), 2.93 (s, 12H), 1.77 (s, 12H). 13C NMR 
(101 MHz, CDCl3) δ 151.62, 146.23, 132.82, 114.72, 26.33, 21.74, (C-B not detected). HRMS (ESI): m/z calculated 
for C30H37B2FeN8O6 [M+H]+ 683.2372, found 683.2383. 
The NMR spectra for these clathrochelates are included in the supporting information of the publication 
cited under reference 79.   
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Cages 2.1−2.5 
The respective clathrochelate complex (CC2.1, 2, 3, 4, or 5; 3 eq.) and the iron salt (Fe(OTf)2 or Fe(NTf2)2) (2 eq.) 
were dissolved in acetonitrile (20 mL). The complementary small molecule (6 eq. p-toluidine for CC2.1− CC2.3, 
or 6 eq. 2-formylpyridine for CC2.4 and CC2.5) was added and the reaction mixture was stirred at 50 °C 
overnight. The solvent was removed under reduced pressure, and the residue was re-dissolved in acetonitrile 
(5 mL) and precipitated with diethyl ether containing 10% pentane (10 mL). The resulting solid was washed 
once with a mixture of diethyl ether and pentane (1:1, 15 mL), and once with CHCl3 (15 mL). Drying under 
vacuum gave the respective coordination cage in high yield. Further details about the syntheses can be found 
in Table ES1 and analytical data of the cages are listed below. 
 
 3 eq. 
Ligand 
2 eq. 
Fe(OTf)2 
6 eq. 
p-toluidine 
6 eq. 
2-formyl- 
pyridine 
Yield cage 
 
Ligand 
# 
Cage 
# 
mg µmol mg µmol mg µmol mg µmol mg µmol % 
CC2.1 2.1 40 63 15 42 14 126 - - 64 10 98 
CC2.2 2.2a 40 56 13 38 12 113 - - 59 4 93 
CC2.3 2.3a 40 56 13 37 12 112 - - 60 4 95 
CC2.4 2.4a 40 66 16 44 - - 14 132 65 11 97 
CC2.5 2.5 40 58 14 39 - - 13 117 59 9 92 
 3 eq. 
Ligand 
2 eq. 
Fe(NTf2)2 
6 eq. 
p-toluidine 
6 eq. 
2-formyl- 
pyridine 
Yield cage 
 
CC2.2 2.2b 40 56 24 38 12 113 - - 70 5 93 
CC2.3 2.3b 40 56 24 37 12 112 - - 68 4 93 
CC2.4 2.4b 40 66 28 44 - - 14 132 72 10 97 
Table ES1. Details for the synthesis of the cages 2.1−2.5. 
The full characterisation data for these complexes are included in the supporting information of the publication 
cited under reference 79. 
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Single crystal X-ray analysis 
Intensity data for the clathrochelates CC2.1 was measured at low temperature [120(2) K or 100(2) K] using Mo 
Kα radiation on a Bruker APEX II CCD diffractometer equipped with a kappa geometry goniometer. The dataset 
was reduced by EvalCCD[151] and then corrected for absorption.[152] Molecular graphics and publication material 
were produced with Olex2.[112] 
Intensity data for building blocks CC2.4, CC2.5 and cage 2.4b, were collected at the Swiss Norwegian beamline 
BM01A at the ESRF in Grenoble (France) equipped with a Pilatus2M pixel detector from Dectris Ltd. Data 
collection was performed at low temperature [120 K] using a Cryostream 700 Series from Oxford Cryosystems 
Ltd. Data integration was carried out using CrysAlis Pro. Multi-scan empirical absorption corrections were 
applied to the data using CrysAlis Pro. Despite the use of synchrotron radiation, few reflections at greater than 
1.1 Å resolution were observed for 2.4b. Nevertheless, the quality of the data is far more than sufficient to 
establish the connectivity of the structures. 
Intensity data for cage 2.5 were collected using a Bruker D8 VENTURE equipped with high-brilliance IμS Cu-
Kα radiation (1.54178 Å) with ω and ψ scans at low temperature [135(2) K]. Data integration and reduction 
were undertaken with SAINT. A multi-scan empirical absorption correction was applied to the data using 
SADABS. Despite the use of a high-intensity laboratory source, few reflections at greater than 1.1 Å resolution 
were observed. Nevertheless, the quality of the data is clearly sufficient to establish the connectivity of the 
structure.  
All the structures were solved and refined with SHELX.[153] Fourier map of compounds CC2.1, 2.4b and 2.5 were 
treated by the SQUEEZE algorithm of PLATON.[154] Disorder was modeled using standard crystallographic 
methods including constraints and restraints where necessary. Thermal parameter restraints (SIMU, DELU 
and/or RIGU) were applied to the anisotropic displacement parameters of anions and solvent molecules 
(MeCN, DMF, Me2CO and Et2O) and to all non-metal atoms in the structures of cage 2.4b. Geometrical 
restraints (SADI or DFIX) were also applied to the anions and solvent molecules, as well to some bond distances 
within the cages to ensure a reasonable refinement. For 2.4b bond lengths and angles within pairs of organic 
ligands were restrained to be similar to each other. Several anions in the structures of the cages were modeled 
as disordered over two or three locations and/or with fractional occupancy. Some disordered anions and 
solvent molecules were modeled with isotropic thermal parameters. Carbon-bound hydrogen atoms were 
included in idealized positions and refined using a riding model. The contribution of the electron density 
associated with disordered counter anions and solvent molecules, which could not be modeled with discrete 
atomic positions were handled using the SQUEEZE routine in PLATON to generate solvent masks (.fab files) 
which were included in the SHELX refinement via the ABIN instruction leaving the original structure factors 
untouched.  
Crystallographic data have been deposited to the CCDC and correspond to the following codes: CC2.1 
(1442394), CC2.4 (1442248), CC2.5 (1442090), 2.4b (1442396) and 2.5 (1442397). Copies of the data can be 
obtained free of charge on application to the CCDC, 12 Union Road, Cambridge, CB2 1EZ, U.K. (fax, (internat.) 
+44-1223-336033; E-mail, deposit@ccdc.cam.ac.uk). 
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Single crystals of sufficient quality for X-ray analysis were obtained by using the following methods: 
CC2.1: Slow diffusion of hexane into a solution of the clathrochelate in DCM.  
CC2.4: Slow diffusion of diethylether into a solution of the HCl salt of the clathrochelate in MeOH.  
CC2.5: Slow diffusion of diethylether into a solution of the HCl salt of the clathrochelate ligand in MeOH.  
2.4b: Slow diffusion of diethylether into a solution of the NTf2 salt of the cage in CH3CN.  
2.5: Slow diffusion of hexane into a solution of the OTf salt of the cage in acetone with the addition of a drop 
of concentrated solution of KSbF6. 
 
VOIDOO calculations on 2.4b and 2.5 
The available void space in cages 2.4b and 2.5 was determined by VOIDOO calculations.15 Based on the crystal 
structures of these cages (anions and solvent molecules are removed from the structure for the calculations), 
the calculations were performed with standard parameters, with the exception of the following parameters: 
Maximum number of volume refinement cycles:   30  
Minimum size of secondary grid:     3  
Grid for plot files:       0.2 
Primary grid spacing:       0.1  
Plot grid spacing:       0.1  
It is observed that cage 2.4 has a significantly bigger cavity then cage 2.5, namely 480 A3 vs. 377 A3, on average. 
As shown in the Figure 2.5, the cavity in cage 2.5 (right) is partly blocked due to the bulky side groups of 
clathrochelate ligand CC2.5.  
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Experimental section Chapter 3 
Commercial sources: 1,3-dibromopropane – AlfaAesar, 1,3-phenylenediboronic acid – FluoroChem, 
1,4-dibromobenzene - VWR International SA, 1,5 dibromopentane – TCI, 4-bromobenzaldehyde – Maybridge, 
4-bromophenol – Sigma Aldrich, dimethylglyoxime – Apollo Scientific, iron(II)chloride anhydrous – VWR 
International SA, nioxime – TCI, p-tolylboronic acid – Sigma Aldrich, pyridine-3-boronic acid – FluoroChem and 
[Pd(CH3CN)4](BF4)2 – ABCR 
 
Synthetic procedures 
Bis(bromophenyl)methane (I) was synthesized following a literature procedure.[155] 
 
 
Scheme ES3: Synthesis of diboronic acid J from bis(4-bromophenyl)methane (I). 
A solution of bis(4-bromophenyl)methane (I) (3.0 g, 9.2 mmol) in THF (40 mL) was cooled to −78°C. 
N-butyllithium in hexane (2.5 M, 8.1 mL, 20.2 mmol, 2.2 eq.) was slowly added and stirred for an additional 
30 min before triisopropylborate (3.8 g, 4.7 mL, 20.2 mmol, 2.2 eq.) was added. The reaction mixture was then 
left to warm up to r.t. overnight. Aqueous HCl (1 M, 20 mL) was added to quench the reaction and the solvent 
was removed under reduced pressure. A solid was collected, which was washed with water (3 × 50 mL) and 
with a 1:1 pentane/DCM mixture (2 × 50 mL) and dried by air. Diboronic acid J was obtained in the form of a 
white powder (1.9 g, 5.8 mmol, 63%). 
1H NMR (400 MHz, DMSO-d6) δ 7.91 (s, 4H), 7.66 (d, J = 7.5 Hz, 4H), 7.14 (d, J = 7.6 Hz, 4H), 3.89 (s, 2H). 13C NMR 
(101 MHz, DMSO-d6) δ 143.06, 134.31, 127.81, 40.15, (C-B not detected). HRMS (ESI): m/z calculated for 
C17H22B2NaO4 [M+4 CH2+Na] + (4 × methoxy adduct, from methanol as solvent) 335.1602, found 335.1609. 
The NMR spectra for this dioboronic acid are included in the supporting information of the publication cited 
under reference 80b.   
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Scheme ES4: Synthesis of diboronic acid L. 
4-Bromophenol (10 g, 57.8 mmol, 2 eq.), 1,3-dibromopropane (5.8 g, 28.9 mmol 1 eq.) and K2CO3 (60 g, 
780 mmol 7.5 eq.) were added to acetone (250 mL) and the mixture was heated under reflux overnight. The 
reaction mixture was cooled to r.t. and the white solid was filtered and washed with acetone (200 mL) and DCM 
(100 mL). The organic layer was evaporated under reduced pressure to obtain the dibromo compound K as a 
white powder (7.2 g, 18.7 mmol, 65%). 
1H NMR (400 MHz, CD2Cl2) δ 7.37 (d, J = 8.9 Hz, 4H), 6.81 (d, J = 8.9 Hz, 4H), 4.11 (t, J = 6.1 Hz, 4H), 2.23 (p, J = 
6.1 Hz, 2H). 13C NMR (101 MHz, CD2Cl2) δ 158.66, 132.76, 116.88, 113.22, 65.21, 29.67. HRMS (APCI): m/z 
calculated for C15H15Br2O2 [M+H]+ 385.9341, found 385.9327. 
A solution of the dibromo starting material K (5.0 g, 13.0 mmol) in THF (40 mL) was cooled to −78°C. 
N-butyllithium in hexane (2.5 M, 11.4 mL, 28.59 mmol, 2.2 eq.) was slowly added and stirred for an additional 
30 min before triisopropylborate (5.4 g, 6.6 mL, 28.5 mmol, 2.2 eq.) was added. The reaction mixture was then 
left to warm up to r.t. overnight. Aqueous HCl (1 M, 10 mL) was added to quench the reaction and the solvent 
was removed under reduced pressure. A solid was collected, which was washed with water (3 × 50 mL) and 
with a 1:1 DCM/MeOH mixture (2 × 50 mL) and dried by air. The diboronic acid L was obtained in the form of 
a white powder (1.2 g, 3.8 mmol, 29%). 
1H NMR (400 MHz, DMSO-d6) δ 7.83 (s, 4H), 7.73 (d, J = 8.3 Hz, 4H), 6.91 (d, J = 8.4 Hz, 4H), 4.15 (t, J = 6.1 Hz, 
4H), 2.18 (p, J = 5.9 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ 160.15, 135.85, 113.42, 63.93, 28.63, (C-B not 
detected). HRMS (ESI): m/z calculated for C19H26B2NaO6 [M+4 CH2+Na] + (4 × methoxy adduct, from methanol 
solvent) 395.1813, found 395.1811. 
The NMR spectra for this dioboronic acid are included in the supporting information of the publication cited 
under reference 80b.   
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Scheme ES5: Synthesis of diboronic acid M.  
4-Bromophenol (10 g, 57.8 mmol, 2 eq.), 1,5-dibromopentane (6.7 g, 28.9 mmol 1 eq.) and K2CO3 (60 g, 
780 mmol 7.5 eq.) were added to acetone (250 mL) and the mixture was heated under reflux overnight. The 
reaction mixture was cooled to r.t. and the white solid was filtered of and washed with acetone (200 mL). The 
organic layer was evaporated under reduced pressure and the remaining solid was washed with hexane (50 mL) 
and dried to obtain the dibromo compound M as a white powder (5.1 g, 12.4 mmol, 45%). 
1H NMR (400 MHz, CD2Cl2) δ 7.37 (d, J = 8.9 Hz, 4H), 6.79 (d, J = 8.9 Hz, 4H), 3.95 (t, J = 6.4 Hz, 4H), 1.83 (p, 
J = 6.6 Hz, 4H), 1.62 (p, J = 7.7, 7.1 Hz, 2H). 13C NMR (101 MHz, CD2Cl2) δ 158.87, 132.71, 116.86, 112.96, 68.63, 
29.46, 23.16. HRMS (APCI): m/z calculated for C17H19Br2O2 [M+H]+ 414.9732, found 414.9724 
A solution of the dibromo starting material M (3.0 g, 7.2 mmol) in THF (40 mL) was cooled to −78°C. 
N-butyllithium in hexane (2.5 M, 6.4 mL, 15.9 mmol, 2.2 eq.) was slowly added and stirred for an additional 
30 min before triisopropylborate (3.0 g, 3.7 mL, 15.9 mmol, 2.2 eq.) was added. The reaction mixture was then 
left to warm up to r.t. overnight. Aqueous HCl (1 M, 20 mL) was added to quench the reaction and the solvent 
was removed under reduced pressure. A solid was collected, which is washed with water (3 × 50 mL) and with 
a 1:1 pentane/DCM mixture (2 × 50 mL) and dried by air. The diboronic acid N was obtained in the form of a 
white powder (1.8 g, 4.3 mmol, 61%). 
1H NMR (400 MHz, DMSO-d6) δ 7.82 (s, 4H), 7.70 (d, J = 7.5 Hz, 4H), 6.86 (d, J = 7.5 Hz, 4H), 3.98 (t, J = 6.0 Hz, 
4H), 1.86 – 1.69 (m, 4H), 1.69 – 1.40 (m, 2H). 13C NMR (101 MHz, DMSO-d6) δ 174.83, 150.31, 127.88, 81.57, 
42.93, 36.76, (C-B not detected). HRMS (ESI): m/z calculated for C21H30B2NaO6 [M+4 CH2+Na] + (4 × methoxy 
adduct, from methanol solvent) 423.2126, found 423.2140. 
The NMR spectra for this dioboronic acid are included in the supporting information of the publication cited 
under reference 80b.   
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Scheme ES6. Synthesis of double clathrochelate L3.1–L3.6 
Anhydrous FeCl2 (4 eq.) and the respective dioxime (12 eq.) were dissolved in MeOH (15 mL). In a separate 
flask, the respective diboronic acid (100 mg, 1 eq.) and 3-pyridine boronic acid (6 eq.) were dissolved in 
methanol (130 mL), acetone (5 mL), and water (2 mL) and heated to reflux and stirred for 30 min. The pre-
prepared mixture of dioxime and FeCl2, was added to the boronic acid mixture, the mixture was heated to 
reflux for an additional 2 h, before the solvent was removed under reduced pressure. The remaining solid was 
dissolved in CHCl3 (100 mL), filtered and washed with a saturated aqueous solution of sodium EDTA and 5% 
ammonia (100 mL). The organic phase was dried over MgSO4, and evaporated under reduced pressure. The 
solid was pre-purified by a short silica column (150 g silica, 10% MeOH in DCM) to remove any polymeric 
material. The dark red fractions were evaporated under reduced pressure, the solid was dissolved in DCM 
(10 mL), filtered over H-PTFE 20/25 syringe filters and separated on a size exclusion column (200 g, dry weight, 
Bio-Beads S-X3 in DCM). The pure fractions (checked by MS, positive mode), were combined and washed with 
saturated NaHCO3 solution, dried over MgSO4 and the solvent was removed under reduced pressure to yield 
a red powder as the double clathrochelate. 
Tables ES2: Amounts used for the synthesis of double clathrochelates L3.1–L3.6. BA is boronic acid, CC is 
clathrochelate. In the places where there is no specific diboronic acid stated (L3.1 and L3.2) the starting 
material was 1,3-phenylboronic acid. 
Double 
CC 
Di-BA 4 eq. FeCl2 12 eq. nioxime 1 eq. Di BA 6 eq. 3-
pyridineBA 
Yield double 
clathrochelate 
# # mg mmol mg mmol mg mmol mg µmol mg mmol % 
L3.1 - 306 2.4 1029 7.2 100 0.60 445 3.6 435 0.35 59 
L3.3 J 198 1.6 667 4.7 100 0.39 288 2.3 262 0.20 51 
 
Double 
CC 
Di-BA 4 eq. FeCl2 12 eq. 
dimethyl-
glyoxime 
1 eq. Di BA 6 eq. 3-
pyridineBA 
Yield double 
clathrochelate 
# # mg mmol mg mmol mg mmol mg µmol mg mmol % 
L3.2 - 306 2.4 841 7.2 100 0.60 445 3.6 264 0.25 41 
L3.4 J 198 1.6 545 4.7 100 0.39 288 2.3 177 0.15 39 
Double 
CC 
Di-BA 4 eq. FeCl2 12 eq. 
nioxime 
1 eq. Di BA 6 eq. 3-
pyridineBA 
Yield double 
clathrochelate 
# # mg mmol mg mmol mg mmol mg µmol mg mmol % 
L3.5 L 160 1.3 540 3.8 100 0.32 233 1.9 326 0.24 48 
L3.6 N 147 1.2 496 3.5 100 0.29 214 1.7 200 0.14 49 
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L3.1: 1H NMR (400 MHz, CD2Cl2) δ 8.72 (s, 2H), 8.43 (d, J = 3.5 Hz, 2H), 7.88 (d, J = 6.4 Hz, 3H), 7.51 (d, J = 7.3 
Hz, 2H), 7.21 - 7.16 (m, 3H), 2.85 (d, J = 13.4 Hz, 24H), 1.74 (s, 24H). 13C NMR (101 MHz, CD2Cl2) δ 152.98, 152.74, 
152.32, 148.90, 140.22, 135.74, 131.72, 126.81, 123.50, 26.81, 26.75, 22.20, (C-B not detected). HRMS (ESI): m/z 
calculated for C52H62B4Fe2N14O12 [M+2H]2+ 615.1888, found 615.1895. 
L3.2: 1H NMR CD2Cl2) δ 8.91 (s, 2H), 8.58 (broad d, 2H), 8.11 (s, 1H), 8.03 (d, J = 7.3 Hz, 2H), 7.72 (d, J = 7.3 Hz, 
2H), 7.38 (t, J = 7.3 Hz, 1H), 7.36 – 7.27 (m, 2H), 2.50 (s, 18H), 2.47 (s, 18H). 13C NMR 13C NMR (101 MHz, CD2Cl2) 
δ 152.92, 152.41, 152.00, 148.82, 139.19, 135.04, 131.25, 126.31, 122.81, 13.10, (C-B not detected). HRMS (ESI): 
m/z calculated for C40H50B4Fe2N14O12 [M+2H]2+ 537.1407, found 537.1396. 
L3.3: 1H NMR (400 MHz, CD2Cl2) δ 8.80 (s, 2H), 8.50 (broad d, 2H), 7.92 (d, J = 7.1 Hz, 2H), 7.57 (d, J = 7.5 Hz, 
4H), 7.25 – 7.17 (m, 6H), 3.98 (s, 2H), 2.91 (s, 24H), 1.81 (s, 24H). 13C NMR (101 MHz, CD2Cl2) δ 153.48, 152.74, 
152.46, 149.41, 141.77, 139.75, 132.29, 128.45, 123.34, 42.61, 26.77, 22.16, (C-B not detected). HRMS (ESI): m/z 
calculated for C59H68B4Fe2N14O12 [M+2H]2+ 660.2124, found 660.2134. 
L3.4: 1H NMR (400 MHz, CD2Cl2) δ 8.89 (s, 2H), 8.57 (broad d, 2H), 8.02 (d, J = 6.5 Hz, 2H), 7.67 (d, J = 6.9 Hz, 
4H), 7.38 – 7.05 (m, 6H), 4.05 (s, 2H), 2.46 (s, 36H). 13C NMR (101 MHz, CD2Cl2) δ 152.92, 152.43, 152.15, 148.84, 
141.23, 139.19, 131.76, 127.87, 122.79, 42.07, 13.13, 13.10, (C-B not detected). HRMS (ESI): m/z calculated for 
C47H56B4Fe2N14O12 [M+2H]2+ 582.1640, found 582.1631. 
L3.5: 1H NMR (400 MHz, CD2Cl2) δ 8.81 (s, 2H), 8.51 (broad d, 2H), 7.97 (d, J = 7.1 Hz, 2H), 7.57 (d, J = 8.1 Hz, 
4H), 7.27 (t, J = 8.0 Hz, 2H), 6.89 (d, J = 8.1 Hz, 4H), 4.18 (t, J = 5.9 Hz, 4H), 2.91 (s, 24H), 2.27 (t, J = 8.0 Hz 2H), 
1.81 (s, 24H). 13C NMR (101 MHz, CD2Cl2) δ 159.48, 152.85, 152.77, 152.41, 148.78, 140.34, 133.40, 123.53, 
114.11, 65.02, 30.04, 26.78, 22.15, (C-B not detected). HRMS (ESI): m/z calculated for C61H72B4Fe2N14O14 
[M+2H]2+ 690.2230, found 690.2236. 
L3.6: 1H NMR (400 MHz, CD2Cl2) δ 8.80 (s, 2H), 8.51 (s, 2H), 7.93 (d, J = 6.1 Hz, 2H), 7.56 (d, J = 7.3 Hz, 4H), 7.24 
(s, 2H), 6.87 (d, J = 6.9 Hz, 4H), 4.02 (broad t, 4H), 2.91 (s, 24H), 1.92-1.75 (m, 28H), 1.68 (broad t, 2H). 13C NMR 
(101 MHz, CD2Cl2) δ 159.66, 153.35, 152.40, 149.29, 139.88, 133.37, 123.38, 114.09, 68.18, 29.78, 26.78, 23.33, 
22.16, (C-B not detected). HRMS (ESI): m/z calculated for C63H76B4Fe2N14O14 [M+2H]2+ 704.2387, found 
704.2383. 
The NMR spectra for these ligands are included in the supporting information of the publication cited under 
reference 80b.   
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Cages 3.1−3.6 
To the double clathrochelate ligand (see Table ES3 for amounts, 2.2 µmol, 2 eq.) and [Pd(CH3CN)4](BF4)2 (0.5 
mg, 1.1 µmol, 1 eq.) 0.6 mL of solvent (CD3CN or DMSO-d6) was added. The solution was heated at 70 °C for 
17 h, in which the solution went from turbid to a clear red solution with everything dissolved. NMR shows full 
conversion to yield the Pd2L4 coordination cages. (except in the cases of double clathrochelate (L3.5) and (L3.6) 
where there was a small amount of precipitate).  
 
Table ES3: The amounts of the double clathrochelates used for the synthesis of the PdII2L4 coordination cages. 
 
 
 
 
 
The full characterisation data for these complexes are included in the supporting information of the publication 
cited under reference 80b. 
  
Double clathrochelate # Amount used (mg) 
L3.1 2.8 
L3.2 2.4 
L3.3 3.0 
L3.4 2.6 
L3.5 3.1 
L3.6 3.2 
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Destruction experiments 
 
Figure ES1. 1H NMR spectrum of cage 3.1 in CD3CN (top) and after the addition of 2 eq. of [Pd(CH3CN)4](BF4)2 
and heating at 70 °C for 2 h to fully equilibrate the sample. 
 
 
 
Figure ES2. 1H NMR spectrum of cage 3.2 in CD3CN (top) and after the addition of 2 eq. of [Pd(CH3CN)4](BF4)2 
and heating at 70 °C for 2 h to fully equilibrate the sample.   
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Figure ES3. 1H NMR spectrum of cage 3.3 in DMSO-d6 (top) and after the addition of 16 eq. of pyridine-d5 and 
heating at 70 °C for 2 h to fully equilibrate the sample. 
 
 
Figure ES4. 1H NMR spectrum of cage 3.4 in DMSO-d6 (top) and after the addition of 16 eq. of pyridine-d5 
and heating at 70 °C for 2 h to fully equilibrate the sample. 
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Single crystal X-ray analysis 
Intensity data for all ligands and cages were collected on a Rigaku SuperNova dual system in combination with 
an Atlas CCD detector using Cu-Kαradiation (λ = 1.54178 Å) at 140.0(2) K. The solutions were obtained by 
SHELXT; and the refinements were carried out by SHELXL-2014[153] and OLEX2[112] programs. The crystal 
structures were refined using full-matrix least-squares based on F2 with anisotropically refined non-hydrogen 
atoms (except some disordered -nioxime fragments and solvent molecules which were refined in isotropic 
approximation). The anions in cages (all disordered and some ordered ones) were refined isotropically with Uiso 
and B-F and B...B distances fixed. Hydrogen atoms were placed in calculated positions by means of the “riding” 
model. Additional electron density found in the difference Fourier map of cage 3.1-3.3, 3.5, 3.6 was treated 
by the SQUEEZE algorithm of PLATON and refined using ABIN instruction because of presence of a twinned 
component. Unfortunately, weak reflection ability and presence of a twinned component resulted in poor 
convergence factors for 3.2 and 3.5. Nevertheless, the quality of the data is clearly sufficient to establish the 
connectivity of these structures. Intense disorder affected solvent molecules of L3.1, L3.2, 3.1, 3.3, 3.6 and 
several moieties of crystal structures 3.1, 3.2 and 3.5 tough restraints/constraints (involving SHELX commands: 
DFIX, SADI, SIMU, RIGU, EADP and ISOR) were used to handle it.  
Crystallographic data have been deposited with the CCDC no. 1511090−1511096. Copies of the data can be 
obtained free of charge on application to the CCDC, 12 Union Road, Cambridge, CB2 1EZ, U.K. (fax, (internat.) 
+44-1223-336033; E-mail, deposit@ccdc.cam.ac.uk). 
 
Single crystals of sufficient quality for X-ray analysis were obtained by using slow diffusion with the following 
solvents: 
L3.1 and L3.2 DCM and diethyl ether  
Cage 3.1 CH3CN and diethyl ether 
Cage 3.2 20% CH3CN in DMSO and dietheyl ether 
Cage 3.3 20% CH3CN in DMSO and isopropylether 
Cage 3.5 20% CH3CN in DMSO and isopropylether 
Cage 3.6 20% CH3CN in DMSO and diethylether 
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Experimental section Chapter 4 
Commercial sources: anhydrous iron(II) chloride – Acros, nioxime – ABCR, bis(triphenylphosphine)palladium(II) 
dichloride – Sigma Aldrich, 1,3,5-tribromobenzene – Apollo Scientific, 1,3,5-tris(4-bromophenyl)benzene – TCI, 
bis(pinacolato)diboron – FluoroChem, sodium (meta)periodate – Sigma Aldrich, pyridine-3-boronic acid – 
FluoroChem, [Pd(CH3CN)4](BF4)2 – ABCR 
Synthetic procedures  
 
Scheme ES7. Synthesis of triboronic acid Q. 
1,3,5-Tribromobenzene O (10.0 g, 32 mmol), bis(pinacolato)diboron (26.6 g, 105 mmol, 3.3 eq.), KOAc (10.3 g, 
105 mmol, 3.3 eq.), and PdCl2(PPh3)2 (1.3 g, 1.9 mmol, 0.06 eq.) were combined in a round bottom flask. 
Degassed dioxane (250 mL) was added and the reaction was stirred at 120 °C overnight. The reaction is cooled 
to r.t., filtered, dried under reduced pressure and purified by silica column chromatography (gradient of 20% 
to 50% EtOAc in Hexane). The pure fractions were dried under reduced pressure, which yielded a white powder 
which was verified by 1H NMR to be the triboronate ester P (9.8 g, 21.5 mmol, 67%). The latter was used directly 
for the deprotection reaction described below. 
1H NMR (400 MHz, CDCl3) δ 8.36 (s, 3H), 1.33 (s, 36H). 
The deprotection reaction was carried out by a modified method of a published procedure.[97b] The triboronate 
ester P (9.8 g, 21.5 mmol) and sodium (meta)periodate (41.3 g, 194 mmol, 9 eq.) were suspended in a mixture 
of THF (240 mL) and H2O (60 mL) and stirred at r.t. overnight. Aqueous HCl (2 M, 5 mL) were added and the 
reaction mixture was stirred for 24 h. Methanol (600 mL) was added, the mixture was filtered and concentrated 
under reduced pressure. Aqueous HCl (1M, 300 mL) was added and the mixture was left to stir for 2 h at r.t.. 
The white solid was collected by filtration and dried by air to yield the triboronic acid Q (3.8 g, 18.3 mmol, 85%). 
1H NMR (600 MHz, DMSO-d6) δ 8.15 (s, 3H), 7.81 (s, 6H). 13C NMR (151 MHz, DMSO-d6) δ 141.98, 131.61 (weak, 
C-B). HRMS (ESI): m/z calculated for C11H19B3NaO6+, (Cationized with Na and 5 × methoxy adducts, from 
methanol as solvent) 303.1358, found 303.1368 (3.1 ppm).  
The NMR data for this triboronic acid are included in the supporting information of the publication cited under 
reference 104. 
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Scheme ES8. Synthesis of triboronic acid T. 
1,3,5-Tris(4-bromophenyl)benzene R (5.0 g, 9.2 mmol), bis(pinacolato)diboron (7.7 g, 30.4 mmol, 3.3 eq.), KOAc 
(3.0 g, 30.4 mmol, 3.3 eq.), and PdCl2(PPh3)2 (0.39 g, 0.18 mmol, 0.06 eq.) were combined in a round bottom 
flask. Degassed dioxane (100 mL) was added and the reaction was stirred at 120 °C overnight. The reaction was 
cooled to r.t., filtered, dried under reduced pressure, and purified by silica column chromatography (gradient 
of 20% to 50% EtOAc in Hexane). The pure fractions were dried under reduced pressure, which yielded a white 
powder which was verified by 1H NMR to be the triboronate ester S (5.3 g, 7.7 mmol, 84%). The latter was used 
directly for the deprotection reaction described below.  
1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 7.6 Hz, 6H), 7.82 (s, 3H), 7.71 (d, J = 7.5 Hz, 6H), 1.38 (s, 36H). 
The deprotection reaction was carried out by a modified method of a published procedure.[97b]S1 The 
triboronate ester S (5.3 g, 7.7 mmol) and sodium (meta)periodate (14.7 g, 69 mmol, 9 eq.) were suspended in 
a mixture of THF (100 mL) and H2O (25 mL) and stirred at r.t. overnight. Aqueous HCl (2 M, 2 mL) were added 
and the reaction mixture was stirred for 24 h. Methanol (400 mL) was added, the mixture was filtered and 
concentrated under reduced pressure. Aqueous HCl (1M, 120 mL) was added and the mixture was left to stir 
for 2 h at r.t.. The white solid was collected by filtration and dried by air to yield the triboronic acid T (3.2 g, 7.3 
mmol, 95%). 
1H NMR (400 MHz, DMSO-d6) δ 8.11 (s, 6H), 7.93 (d with s overlapping, 9H), 7.85 (d, J = 7.7 Hz, 6H). 13C NMR 
(101 MHz, DMSO-d6) δ 141.58, 141.50, 134.78, 126.15, (C-B not detected). HRMS (ESI): m/z calculated for 
C29H30B3NaO6+ +, (Cationized with Na and 5 × methoxy adducts, from methanol as solvent) 531.2317, found 
531.2313 (0.8 ppm). 
The NMR data for this triboronic acid are included in the supporting information of the publication cited under 
reference 104. 
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Scheme ES9. Synthesis of the metalloligands L4.1 and L4.2. 
Anhydrous FeCl2 (4 eq.) and the respective dioxime (12 eq.) were dissolved in MeOH (15 mL). In a separate 
flask, the respective triboronic acid (100 mg, 1 eq.) and 3-pyridine boronic acid (5 eq.) were dissolved in 
methanol (20 mL), acetone (5 mL), and chloroform (150 mL) and heated to reflux and stirred for 30 min. The 
pre-prepared mixture of dioxime and FeCl2, was added to the boronic acid mixture, the mixture was heated to 
reflux for an additional 3 h, before the solvent was removed under reduced pressure. The remaining solid was 
dissolved in CHCl3 (100 mL), filtered and washed with a saturated aqueous solution of sodium EDTA and 5% 
ammonia (100 mL). The organic phase was dried over MgSO4, and evaporated under reduced pressure. The 
solid was pre-purified by a short silica column (150 g silica, 10% MeOH in DCM) to remove any polymeric 
material. The dark red fractions were evaporated under reduced pressure, the solid was dissolved in DCM (10 
mL), filtered over H-PTFE 20/25 syringe filters and separated on a size exclusion column (200 g, dry weight, 
Bio-Beads S-X3 in DCM). The pure fractions (checked by MS, pos. mode), were combined and washed with 
saturated NaHCO3 solution, dried over MgSO4, and the solvent was removed under reduced pressure to yield 
a red powder. 
Table ES4. Amounts used for the synthesis of the metalloligands L4.1 and L4.2. BA is boronic acid, CC is 
clathrochelate. 
Ligand tri-BA 4 eq. FeCl2 12 eq. 
nioxime 
1 eq. tri-BA 5 eq.                  
3-pyridine BA 
Yield 
# # mg mmol mg mmol mg mmol mg mmol mg mmol % 
L4.1 Q 290 2.3 977 6.9 120 0.60 352 2.9 435 0.35 57 
L4.2 T 198 1.6 667 4.7 100 0.39 288 2.3 262 0.20 49 
 
L4.1: 1H NMR (400 MHz, CD2Cl2) δ 8.81 (s, 3H), 8.51 (d, J = 3.5 Hz, 3H), 7.99 – 7.84 (m, 6H), 7.29 – 7.16 (m, 3H), 
2.95 (2 s, 36H), 1.83 (s, 36H). 13C NMR (151 MHz, CD2Cl2) δ 153.49, 152.61, 152.06, 151.81, 149.42, 139.72, 123.33, 
26.79, 26.70, 22.23, 22.19, (C-B not detected). HRMS (ESI): m/z calculated for C75H90B6Fe3N21O18 [M+3H]3+ 
602.1813, found 602.1818 (0.8 ppm).  
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L4.2: 1H NMR (400 MHz, CD2Cl2) δ 8.81 (s, 3H), 8.51 (d, J = 4.8 Hz, 3H), 7.98 – 7.70 (m, 21H), 7.32 – 7.16 (m, 3H), 
2.95 (2 s, 36H), 1.84 (s, 36H). 13C NMR (151 MHz, CD2Cl2) δ 153.48, 152.80, 152.61, 149.45, 143.23, 141.12, 139.72, 
132.73, 125.32, 123.35, 26.82, 26.77, 22.14, (C-B not detected). HRMS (ESI): m/z calculated for 
C93H102B6Fe3N21O18 [M+3H]3+ is 678.2128, found 678.2145 (2.5 ppm).  
The NMR data for the ligands are included in the supporting information of the publication cited under 
reference 104. 
 
 
Scheme ES10. Synthesis of the Pd6L8 coordination cages 4.1 and 4.2 from L4.1 and L4.2 
To the metalloligand (see Table ES5 for amounts, 1.5 µmol, 4 eq.) and [Pd(CH3CN)4](BF4)2 (0.5 mg, 1.1 µmol, 
3 eq.) 0.6 mL of DMSO-d6 was added. The solution was heated at 70 °C for 17 h, in which the solution went 
from turbid to a clear red solution with everything dissolved. NMR shows full conversion to yield the PdII6L8 
coordination cages.  
Table ES5. The amounts of the double clathrochelates used for the synthesis of the M6L8 coordination cages. 
Metalloligand # Amount used (mg) 
L4.1 2.7 
L4.2 3.0 
 
The full characterisation data for these two complexes are included in the supporting information of the 
publication cited under reference 104. 
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Cold-spray ionisation  
Cold-spray ionisation (CSI) MS was performed on a hybrid linear ion trap (LTQ) Orbitrap Elite mass 
spectrometer (Thermo Scientific, Bremen, Germany) equipped with a modified HESI-II probe in an Ion Max ion 
source. In order to perform CSI-MS experiments, the commercial sheath (blue in Figure ES5) and auxiliary 
(green in Figure ES5) gas lines were modified and redirected towards a liquid nitrogen cooling device (black 
in Figure ES5). 
 
Figure ES5. Modified HESI-II probe in an Ion Max ion Source (Thermo Scientific). The sheath gas pathway is 
represented in blue whereas the auxiliary gas line is in green. Both lines are modified and redirected through 
the cooling bath.  
In the probe body, the sheath gas (inner coaxial N2) emerging from the metal needle sprays the sample after 
being redirected through the cooling bath. The auxiliary gas is redirected to the same cooling bath before 
entering a homemade PVC chamber located at the bottom of the source and helping in stabilizing the 
temperature as well as the spray (Figure ES6). 
 
Figure ES6. a) Left side and b) Front/back view of the HESI-II probe with the homemade PVC piece placed at 
the bottom of the Ion Max ion source.  
The PVC piece used to redirect the auxiliary gas is composed of three different parts. The main PVC body 
(Figure ES7a) drives the cooled gas towards the entrance of the Orbitrap. A perforated disk (Figure ES7b) 
Sample
Cooling bath
Sheath Gas
Auxiliary gas
a b
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diffuses the auxiliary gas and is crucial to give a stable signal. Both pieces are attached to the HESI-II probe 
using a third PVC clamp (Figure ES7c).  
 
Figure ES7. Measurements and design of the homemade PVC pieces contained in the CSI source; a) main 
body, b) gas diffuser and c) attachment piece. Values are in mm. 
The spray temperature is dependent on the cooling bath composition and therefore temperature, the length 
of the tubing (inside and outside the bath), the materials chosen for the lines as well as the gas flow rates. 
Therefore, calibration curves were made by placing a thermocouple near the spray, in order to know the instant 
spray temperature under different conditions of gas flow rates. The liquid nitrogen was used as refrigerant in 
the cooling bath, the spray temperature was manually controlled by adjusting both the sheath and the auxiliary 
gas flows, allowing a range of temperature from 20 °C to –50 °C (Figure ES8). For this particular setup applied 
to the mass spectrum measurement of coordination cages, the sheath and auxiliary gas flows were fixed at 
6 and 4, respectively, to obtain a spray temperature around –10 °C. This temperature was shown to be the best 
to both preserve the integrity of coordination cages and obtain sufficient number of ions in the gas phase.  
 
Figure ES8. Measured spray temperatures depending on both sheath and the auxiliary gas flows.  
High resolution mass spectra were acquired for pure, pre-synthesized samples of the cages. The analytes were 
diluted in acetonitrile to a final concentration of ~10-20 μM. The standard XCalibur 2.2 data acquisition and 
instrument control system was utilized (Thermo Scientific). Samples were introduced at a flow rate of 20 µL/min 
and sprayed using an ionization voltage of +1.2 kV and an ion transfer capillary temperature of 80 °C. FT-MS 
a) b)
c)
3.73
25.75
18.30
41.25
38.30
5.35
30.35
95.50
29.10
23.60
72.90
15.00
30.20
60.70
82.55
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spectra were acquired using the high mass range (between 400–4000 m/z) in the reduced profile mode with a 
resolution set to 120'000 at 400 m/z and a target value of charges of 1 million. All Orbitrap FTMS scans were 
recorded averaging 10 microscans to improve the SNR and setting a maximum injection time value at 1000 ms. 
Spartan model cage 4.2 
A model of cage 4.2 was constructed using Spartan and it’s MMF energy minimisation. 
 
Figure ES9. Graphical representation of the structure of cage 4.2 from the Spartan model. Hydrogen atoms 
are omitted for clarity. Grey: C; blue: N; green: B; red: O; cyan: Pd and orange: Fe. 
 
Crystallographic data 
Bragg-intensities of L4.1, L4.2 and the cage 4.1 were measured at low temperature using Cu Kα radiation on 
a Rigaku SuperNova dual system diffractometer equipped with an Atlas CCD detector for the compounds L4.1 
and the cage 4.1 and one equipped with an Atlas S2 CCD detector for the compound L4.2. The datasets were 
reduced and then corrected for absorption, with the help of a set of faces enclosing the crystals as snugly as 
possible, with CrysAlisPro. 
The solutions and refinements for the structures were performed by SHELXT and SHELXL-2018 (release 3),[153] 
respectively. All non-hydrogen atoms were refined anisotropically using full-matrix least-squares based on |F|2. 
All hydrogen atoms were placed in geometrically calculated positions and refined using a riding model where 
each H-atom was assigned a fixed isotropic displacement parameter with a value equal to 1.2 Ueq of its parent 
C-atom. 
The structure of L4.1 was refined as a two-component inversion twin yielding a BASF parameter of 0.48(2). The 
distance similarity restraint (SADI) was needed for the refinement of the cyclohexyl rings. SIMU and RIGU 
restraints were also applied on the displacement parameters of the light atoms. Almost, four highly disordered 
dichloromethane solvent molecules were removed from the model by the SQUEEZE algorithm of PLATON. [154] 
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In the case of L4.2, two cyclohexyl moieties and one pyridine ring were disordered over two orientations. The 
atoms of each orientation were located in a difference Fourier map for each disordered ring. The major and 
minor parts were refined anisotropically, but distance and similarity restraints (SADI and SIMU) were applied 
for a convergent least-squares refinement. RIGU restraint was also applied on the displacement parameters of 
the atoms. Highly disordered solvent molecules were removed with the help of the solvent-masking program 
in OLEX2.[112] 
The structure of cage 4.1 was refined as a two-component inversion twin yielding a BASF parameter of 0.50(4). 
RIGU and SIMU restraints were applied on the displacement parameters of all the atoms and the light atoms, 
respectively. Aromatic groups were restrained to have an ideal hexagonal geometry, using the card AFIX 66. 
Some distance similarity restraints (SADI and DFIX) were applied to the cyclohexyl moieties. Additional counter 
ions and solvent molecules, too disordered to be located in the electron density map, were taken into account 
using the solvent-masking program in OLEX2.[112] 
Crystallographic data have been deposited to the CCDC and correspond to the following codes: L4.1 
(CCDC1849686), L4.2 (1849685), Cage 4.1 (1849687). Copies of the data can be obtained free of charge on 
application to the CCDC, 12 Union Road, Cambridge, CB2 1EZ, U.K. (fax, (internat.) +44-1223-336033; E-mail, 
deposit@ccdc.cam.ac.uk).  
Table ES6. Determined unit cell dimensions from two differently grown crystals of cage 4.2.  
 SJ131 - DMSO SJ125 – DMSO-d6 
cell_length_a 64.286(8)  64.465(8) 
cell_length_b 43.795(3)  43.629(3) 
cell_length_c 76.413(7)  76.113(11) 
cell_volume 193902(30) 192730(30) 
cell_angle_alpha 90.0 90.0 
cell_angle_beta 115.668(14) 115.802(16) 
cell_angle_gamma 90.0 90.0 
Single crystals of sufficient quality for X-ray analysis were obtained by using slow diffusion with the following 
solvents: 
L4.1: Slow diffusion of pentane into a solution of L4.1 in DCM. 
L4.2: Slow diffusion of pentane into a solution of L4.2 in DCM. 
4.1: Slow diffusion of isopropyl acetate into a solution of 4.1 in DMSO with the addition of 24 eq. of NaClO4., 
over the time of several months.  
4.2: Slow diffusion of toluene into a solution of 4.2 in DMSO or DMSO-d6, over the time of several months. 
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VOIDOO calculations cage 4.1 
In order to determine the available void space (probe-occupied volume) within complex 4.1, VOIDOO 
calculations[156] based on the crystal structure were performed. A virtual probe with a radius of 3.0 Å (smallest 
probe-size where the probe didn’t fall out of the cavity) was employed, and the standard parameters were 
used, unless noted below. 
 Maximum number of volume-refinement cycles: 30 
 Minimum size of secondary grid: 3 
 Grid for plot files: 0.3 
 Primary grid spacing: 0.1 
 Plot grid spacing: 0.1 
For complex 1, the following values were found: Volume: 2.79 x 103 Å3 (standard deviation 0.87 Å3), which 
would correspond to a sphere with a radius of 8.74 Å.  
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Experimental section Chapter 5 
Commercial sources: [Pd(CH3CN)4](BF4)2 – ABCR, 1,3-diethynylbenzene – TCI, 3-bromo-4-methoxypyridine – 
Fluorochem, (PPh3)2PdCl2 – Sigma Aldrich, CuI – Sial, Diethylamine – Acros, 1,4-Phenylenediboronic acid – 
Sigma Aldrich, Pd2(dba)3 – TCI, Triphenylphosphine – Roth AG, TFA – Acros, 4-methoxypyridine – TCI, pyridine 
– Fluorochem, DMAP – Fluka, 3-chloropyridine – Apollo, NaTFA – Fluorochem. 
Synthetic procedures  
The ligands L5.1,[120] L5.4,[157] L5.5[66a] and the carbene complex [PdBr2(iPr2-bimy)]2 for the HEP,[158] were 
prepared accoring to literature procedures. 
 
Scheme ES11. Synthesis of L5.3. 
Derived from a literature procedure,[120] ligand L5.3 was synthesized as follows:  
1,3-Diethynylbenzene (0.66 mL, 5.0 mmol), 3-bromo-4-methoxypyridine (1.25 mL, 10.3 mmol, 2.1 eq.), 
(PPh3)2PdCl2 (80 mg, 0.11 mmol), and CuI (15 mg, 0.08 mmol) were combined in a round-bottomed flask and 
degassed. Degassed diethylamine (15 mL) was added and the reaction was heated at 60 °C under nitrogen for 
18 h. Ethyl acetate (100 mL) was added and the mixture was filtered. Water (100 mL) was added to the filtrate, 
the organic layer was separated and the water layer was washed with ethylacetate (2 × 100 mL). The organic 
layers were combined, dried over MgSO4, evaporated under reduced pressure and purified by column 
chromatography (silica, 2-5% MeOH in DCM) to yield ligand L5.3 (351 mg, 1.03 mmol, 21%) as a pale yellow 
solid.  
1H NMR (600 MHz, CD2Cl2) δ = 8.57 (s, 2H), 8.43 (d, J = 5.8, 2H), 7.74 (s, 1H), 7.54 (dd, J = 7.8, 1.6, 2H), 7.39 (t, 
J = 7.8, 1H), 6.87 (d, J = 5.8, 2H), 3.97 (s, 6H).13C NMR (151 MHz, CD2Cl2) δ = 166.07, 154.24, 151.43, 134.97, 
132.07, 129. 26, 123.93, 110.07, 94.99, 83.83, 56.41. HRMS (ESI): m/z calculated for C22H17N2O2 [M+H]+ 341.1285, 
found 341.1296.  
The NMR spectra are included in the supporting information of the publication cited under reference 113. 
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Scheme ES12. Synthesis of L5.4. 
Derived from a literature procedure,[157] ligand L5.4 was synthesized as follows: 
1,4-Phenylenediboronic acid (0.7 g, 4.2 mmol), 3-bromo-4-methoxypyridine (1.54 mL, 12.7 mmol, 3 eq.), 
Pd2(dba)3 (100 mg, 0.11 mmol), and triphenylphosphine (232 mg, 0.89 mmol) were combined in a round 
bottom flask and degassed. To the mixture degassed toluene (125 mL), methanol (20 mL) and 2 M Na2CO3 
(20 mL) was added and the reaction was heated at 70 °C under nitrogen for 18 h. Afterwards, the organic layer 
was separated and the water layer was washed with DCM (3 × 50 mL). The organic layers were combined and 
dried over MgSO4, evaporated under reduced pressure and purified by column chromatography (silica, 2-5% 
MeOH in DCM) to yield ligand L5.4 (264 mg, 1.3 mmol, 27%) as a white solid. 
1H NMR (600 MHz, CD2Cl2) δ = 8.47 (d, J = 5.7, 2H), 8.45 (s, 2H), 7.59 (s, 4H), 6.94 (d, J = 5.7, 2H), 3.90 (s, 6H). 
13C NMR (151 MHz, CD2Cl2) δ = 163.09, 151.15, 134.88, 129.89, 126.46, 107.05, 55.95. HRMS (ESI): m/z calculated 
for C18H16N2O2 [M+H]+ 293.1285, found 293.1285.  
The NMR spectra are included in the supporting information of the publication cited under reference 113. 
Complexes from L5.1 – L5.5 
The ligand (see Table ES7 for amounts, 4.50 µmol, 2 eq.) was added to [Pd(CH3CN)4](BF4)2 (1.0 mg, 2.25 µmol, 
1 eq.) in a mixture of CD3CN and CD3NO2 (8:2) (0.5 mL). The solution was heated at 60 °C for 17 h. During this 
time, the solution went from turbid (in the case of L5.4 and L5.5) to clear. The NMR spectra indicated full 
conversion to the respective assemblies. 
Table ES7. The amounts of the ligands (L5.1 – L5.5) used for the synthesis of the coordination complexes. 
 
 
 
 
 
 
 
 
 
The analytical data of the new complexes resulting from L5.3 and L5.4 are given below. For the characterization 
of the complexes resulting from L5.1[120], L5.2[24] and L5.5,[66a] we would like to refer to the previously published 
results.  
Ligand # Coordination 
complex 
Amount used (mg) Final concentration 
complex (mM) 
L5.1 [PdII2(L5.1)4]4+ 1.26 2.25 
L5.2 [PdII4(L5.2)8]8+ 1.04 1.13 
L5.3 [PdII2(L5.3)4]4+ 1.53 2.25 
L5.4 [PdII3(L5.4)6]6+ 1.31 1.50 
L5.5 [PdII6(L5.5)12]12+ 2.94 0.75 
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Figure ES10. 1H NMR (400 MHz) spectrum (400 MHz) of [PdII2(L5.3)4]4+ in a mixture of CD3CN and CD3NO2 (8:2). 
 
Figure ES11. 1H DOSY NMR (400 MHz) spectrum of [PdII2(L5.3)4]4+ in a mixture of CD3CN and CD3NO2 (8:2).  
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Figure ES12. HRMS of coordination cage [PdII2(L5.3)4]4+ in a mixture of CH3CN and CD3NO2 (95:5). 
 
Figure ES13. HRMS of coordination cage [PdII2(L5.3)4]4+ in a mixture of CH3CN and CD3NO2 (95:5). Zoom-in 
around the 554 m/z region (bottom). Simulated mass spectrum of the +3 charge species of the complex 
[Pd2(L3)4][BF4]3+ (top).  
Experimental section 
-97- 
 
 
Figure ES14. 1H NMR (400 MHz) spectrum of [PdII3(L5.4)6]6+in a mixture of CD3CN and CD3NO2 (8:2). 
 
Figure ES15. 1H DOSY NMR (400 MHz) spectrum of [PdII3(L5.4)6]6+ in a mixture of CD3CN and CD3NO2 (8:2). 
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Figure ES16. HRMS of coordination complex [PdII3(L5.4)6]6+ in a mixture of CH3CN and CD3NO2 (95:5). 
 
Figure ES17. HRMS of coordination complex [PdII3(L5.4)6]6+ in a mixture of CH3CN and CD3NO2 (95:5). Zoom-in 
around the 432 m/z region (bottom). Simulated mass spectrum of the +5 charge species of the complex 
[Pd3(L4)6][BF4]5+ (top).  
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Determination of the ΔpKa 
Two ligands (4.5 µmol, 9 mM for the ligands or 9.0 µmol, 18 mM for the reference compounds) were combined 
in CD3CN or a mixture of CD3CN: CD2Cl2 1:1 (0.5 mL). A stock solution of TFA (57. 4 µL in 1 mL CD3CN, 750 mM) 
was prepared to contain 4.5 µmol per 6 µL stock solution. Per sample there was 2 x 4.5 µmol of ditopic ligands 
(36 mM of pyridine groups) present. With the addition of 6 µL TFA stock solution (9 mM), 0.25 eq. of the total 
amount of pyridine groups were protonated. 
For every combination, there were 6 points recorded, with the last point being 1.25 eq. of acid (45 mM) per 
pyridine group (36 mM) present in solution. The plots below show the average chemical shifts of multiple 
selected signals for each ligand in the mixture with respect to the normalized chemical shift at 1.25 eq. of acid 
(normalized to 100%).  
ΔpKa: ClPy < L5.1 < L5.2 ~ L5.3 < Py < MeOPy ~ L5.4 < L5.5 < DMAP 
A graphical representation of the data for the ΔpKa determination are included in the supporting information 
of the publication cited under reference 113. 
 
Determination of the HEP 
One of the ditopic ligands (4.5 µmol, 9 mM) or reference compounds (9.0 µmol, 18 mM) and the dimeric 
carbene complex (4.2 mg, 4.5 µmol, 9 mM) were combined in CDCl3 (0.5 mL) and after mixing, the 1H and 13C 
spectra were directly recorded. The residual solvent signals from CDCl3 are referenced to 77.7 ppm[122] and the 
13C chemical shift of the carbene signal was reported in ppm in Table 5.1.  
The NMR spectra for the determination of the HEP are included in the supporting information of the 
publication cited under reference 113. 
 
Disassembly of the complexes 
Solutions of the cages were prepared as described above (section 2.2.). Stock solutions of respectively TFA 
(57.4 µL in 1 mL CD3CN, 750 mM) and pyridine-d5 (60.1 µL in 1 mL CD3CN, 750 mM) were prepared to contain 
4.5 µmol TFA per 6 µL stock solution. Per sample, there was a final concentration of 9 mM of ditopic ligands 
and 72 mM of acid or 18 mM of pyridine-d5.  
There is one broad peak visible in the 1H NMR spectra, which is believed to belong to the residual H2O.Due to 
the acidity of the samples, this peak can shift all the way up in the aromatic region in some cases. 
The NMR spectra of the disassembly of the complexes are included in the supporting information of the 
publication cited under reference 113. 
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Acid-mediated switching between different assemblies 
The two respective ligands (4.50 µmol, 9 mM each) were combined and a sub-stoichiometric amount of 
[Pd(CH3CN)4](BF4)2 (1.0 mg, 2.25 µmol, 4.5 mM) and a mixture of CD3CN and CD3NO2 (8:2) (0.5 mL) was added. 
The solution was heated at 60 °C for 17 h. During this time the solution went from turbid (in the case of L5.4 
and L5.5) to clear.  
It was observed that the complex of the most basic ligand was preferentially formed. After addition of acid 
from the TFA stock solution (resulting in an acid concentration of 72 mM, 2 eq. of acid per pyridine group 
present), as described in section 3 and 5, the solution was heated at 60 °C for 2 h to reach the new 
thermodynamic equilibrium, before being measured again.  
There is one broad peak visible in the 1H NMR spectra, which is believed to belong to the residual H2O.Due to 
the acidity of the samples, this peak can shift all the way up in the aromatic region in some cases. The aromatic 
regions of these NMR spectra are shown in Chapter 5 (Scheme 5.4 – 5.7).  
The MS sample was taken at the beginning (before addition of acid) of every reaction and diluted with CH3CN, 
before being measured. 
The MS spectra of the acid-mediated switching between different assemblies are included in the supporting 
information of the publication cited under reference 113. 
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Experimental section Chapter 6 
Commercial sources: 2,2'-dipyridyl – TCI, 2,4,6-tri(4-pyridyl)-1,3,5-triazine – ABCR, iron(II) tetrafluoroborate 
hexahydrate – Sigma Aldrich, pyridine – Sigma Aldrich, sodium tetrakis(4-fluorophenyl)borate hydrate – TCI, 
Pd(CH3CN)4](BF4)2 – ABCR and zinc tetrafluoroborate hydrate – ABCR 
 
Synthetic procedures 
The PdII complex [(dppp)Pd(OTf)2],[66b]and the metallasupramolecular structures 6.5,[66a] 6.7,[80a] 6.8,[80a] 6.9,[159] 
and 6.10[160] were prepared according to literature procedures. 
 
Figure ES18. Chemical structures of model complexes 6.1–6.4. 
General procedure for the synthesis of model complexes (6.1–6.4). For the amounts and metal (complex) 
source used, see the table below. 
Pyridine (5 mg, 0.06 mmol) (for 6.1 and 6.2) or 2,2'-bipyridine (30 mg, 0.19 mmol) (for 6.3 and 6.4) was 
combined with the corresponding metal (complex) in degassed acetonitrile (5 mL). The mixture was stirred at 
r.t. for 18 h, after which diethyl ether (10 mL) was added to precipitate the complex. The solid was collected by 
centrifugation and washed with diethyl ether (10 mL) to obtain the complexes 6.1–6.4. 
Model complex # Metal complex Equivalents of 
ligand to metal 
mg Yield 
6.1 (dppp)Pd(OTf)2 2 15.3 18.2 mg, 60% 
6.2 Pd(CH3CN)4(BF4)2 4 7.0 8.3 mg, 88% 
6.3 Fe(BF4)2 ·6H2O 3 14.7 42.2 mg, 93% 
6.4 Zn(BF4)2·6H2O 3 20.0 34.4 mg, 91% 
Table ES8. Amounts used, and yield for the synthesis of model complexes 6.1–6.4. 
Characterization of model complexes 6.1–6.4.  
6.1: 1H NMR (400 MHz, CD3CN:D2O 4:1) δ = 8.42 (d, J=5.3, 4H), 7.69 – 7.07 (m, 26H), 2.92 (broad s, 2H), 2.16 (tr, 
J=18, 4H). 13C NMR (151 MHz, CD3CN:D2O 4:1) δ 150.62, 140.23, 133.83, 133.77, 133.63, 130.53, 130.45, 127.17, 
122.42, 22.29, 18.45.31P NMR (162 MHz, CD3CN:D2O 4:1) δ 8.2. HRMS (ESI): m/z calculated for C37H36N2P2Pd 
[M-2OTf]2+ 338.0689, found 338.0696 
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6.2: 1H NMR (600 MHz, CD3CN:D2O 4:1) δ = 8.80 (d, J=5.1, 8H), 7.95 (t, J=9.0, 4H), 7.51 (d, J=6.6, 8H). 13C NMR 
(151 MHz, CD3CN:D2O 4:1) δ = 152.00, 142.07, 128.39. HRMS (ESI): m/z calculated for C20H20N4Pd [M-2BF4]2+ 
211.0356, found 211.0360.  
6.3: 1H NMR (600 MHz, CD3CN:D2O 4:1) δ = 8.52 (d, J=6.0, 6H), 8.07 (t, J=6.0, 6H), 7.36 (m, 12H). 13C NMR (151 
MHz, CD3CN:D2O 4:1) δ 160.04, 154.97, 139.67, 128.34, 124.86. HRMS (ESI): m/z calculated for C30H24N6Fe [M-
2BF4]2+ 262.0700, found 262.0700. 
6.4: 1H NMR at 275K (400 MHz, CD3CN:D2O 4:1, 275 K) δ = 8.51 (d, J=8.1, 6H), 8.21 (t, J=7.8, 6H), 7.90 (d, J=2.4, 
6H), 7.53 (t, J=8.1, 6H). 13C NMR (151 MHz, CD3CN:D2O 4:1) δ = 150.10, 148.97, 142.80, 128.39, 124.24. HRMS 
(ESI): m/z calculated for C30H24N6Zn [M-2BF4]2+ 266.0671, found 266.0674. 
The NMR spectra of these complexes are included in the supporting information of the publication cited under 
reference 127. 
General experimental set-up for the photoswitching experiments  
The photoswitching experiments were performed with the use of a Topled (MDE Display + Electronics GmbH) 
SET5050-5M-RGB wrapped around a glass container (see image below). To activate the photoacid, the samples 
were placed in the container and irradiated with violet light (425 nm) for 20 minutes at r.t., unless stated 
otherwise. The samples are then left at r.t. in the dark for the indicated time. 
 
Figure ES19. Experimental set-up for the activation of the photoacid. On the photo on the left side, the LEDs 
are turned off, and on the photo on the right side, they are turned on with the same violet light that was used 
for these experiments.  
The CD3CN/D2O (8:2) solvent mixture was suited to solubilize the photoacid and a range of 
metallasupramolecular structures. All samples were prepared using 2 mg of photoacid (5 µmol in 0.5 mL, 1 
mM). The amount of the metallasupramolecular assembly was adjusted to the amount of the photoacid. We 
used 4 equivalents of photoacid per functional group that can be protonated (so in most cases, per pyridine 
group). For example: the octahedral cage 6.5 has 12 ligands, with 2 pyridine groups per ligand, so (2x12=) 24 
times 4, comes to 96 equivalents of photoacid with respect to the amount of 6.5. The samples were prepared 
and handled in the dark unless stated otherwise. 
The samples were first measured, then irradiated for 20 minutes (indicated by “light”), then measured again, 
and left in the dark for 8 hours (indicated by “dark”), followed by a final measurement. Based on the integration 
of selected signals, the amount of disassembled structure was estimated. When this estimate falls between 
80-100 %, it is indicated with >80%. 
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NMR spectra of the protonated ligands were obtained from samples containing the ligand and an excess of 
HCl (pH around 1).  
The NMR spectra of the reversible disassembly of all complexes 6.1 – 6.10 are included in the supporting 
information of the publication cited under reference 127. 
Repetitive disassembly of barrel 6.8  
The coordination barrel 6.8 was disassembled and re-assembled over 5 cycles. One cycle consists of 20 min 
light exposure, followed by 2.5 h in the dark. The sample contained DCM as an internal standard, and the 
change in integration of three separate signals of the protonated ligand 6D were monitored. 
The NMR spectra of the repetitive reversible disassembly of complex 6.8 are included in the supporting 
information of the publication cited under reference 127. 
 
Kinetic study of the re-assembly processes 
Samples containing the photoacid and the respective metal complex were irradiated for 20 minutes. 1H NMR 
spectra were then recorded after 0, 10, 20, and 30 min (for t = 0 the amount of protonated ligand was 
normalized to 100%). All measurements were performed at 298 K. The signals of the protonated ligand were 
integrated (DCM was used as internal standard) to give the data depicted below. The amount of the protonated 
ligand is expected to be indirectly proportional to the amount of re-assembled metal complex. A direct 
integration of the signals of the supramolecular complexes was hampered by signal overlap with the signals of 
the photoacid. 
A graphical representation of the data from the kinetic study is are included in the supporting information of 
the publication cited under reference 127. 
 
Photoacid-induced switching between [Pd6(6B)12]12+ and [Pd2(6F)4]4+ 
A stock solution was prepared containing 6F (0.9 mg, 3.2 µmol, 2 eq., 1.3 mM) and 6B (2.1 mg, 3.2 µmol, 2 eq., 
1.3 mM) with a sub-stoichiometric amount of [Pd(CH3CN)4](BF4)2 (0.7 mg, 1.6 µmol, 1 eq., 3.2 mM, 0.6 mM) in 
CD3CN and D2O (8:2) (2.5 mL). One fifth of this solution (0.5 mL, with 0.6 µmol, 0.26 mM of each ligand) was 
added to the photoacid (2 mg, 5.2 µmol, 2 eq. of acid per pyridine group in solution, 2.1 mM) in the dark. The 
sample was measured, irradiated with violet light at r.t. for 11 h, measured and kept in the dark at 60 °C for 6 h 
before being measured again (Scheme 6.5). Over the course of the reaction, the photoacid is hydrolyzed to a 
small extent. Therefore, this methodology is not suited to repetitive switching between different structures. 
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